# Sprint 7.14 — Judge Calibration Labeling

## What this is

You're hand-labeling 89 calibration questions (+ 15 holdout in the second file) so we can measure how well different judge candidates (gpt-4o-mini, Sonnet 4.6, Opus 4.7, multi-judge consensus) agree with **your** ground truth verdicts. The shipping gates are Cohen's κ ≥ 0.75 + FPR ≤ 5% on adversarial cases.

## What you do for each record

Read:
1. **Question** — what was asked
2. **Gold answer** — the FinanceBench reference answer
3. **System answer** — what our RAG system produced (full text shown)
4. **Original judge verdict + reason** — what gpt-4o-mini said
5. **Draft label + reason** — my proposed label based on the audit

Decide:
- **PASS** if the system answer conveys the same factual content as gold. Allow:
  - Rounding (5.43% vs 5.4%; 1.3315 vs 1.33)
  - Different units that mean the same (-1.53% vs -0.02 decimal; $1,577M vs 1,577 million USD)
  - Extra context, computation steps, or caveats — judge based on the **final asserted answer**
  - Different phrasing (Las Vegas Strip Resorts ≈ Las Vegas resorts)
- **FAIL** if the system answer:
  - Asserts a different numeric value (wrong number)
  - Says opposite yes/no or trend direction (wrong direction)
  - Refuses to answer when gold gives a definite answer
  - Misses substantively (partial answer with critical drivers missing)

**Adversarial cases (marked CAREFUL REVIEW + ADVERSARIAL)**: I manually corrupted the system answer to be clearly wrong. **All of these should be FAIL.** If you think any are NOT clearly wrong, mark SKIP — that means the corruption wasn't strong enough.

**Dataset_suspect cases** (1 in calibration): the system answer is correct against the actual document, but the gold label is wrong. The judge's job is to match the gold label as written — so the correct label here is **FAIL** (system disagrees with gold). Dataset errors are a separate cleanup.

## How to label

For each record, find the line:

> **MY VERDICT:** `PASS`, `FAIL`, or `SKIP`

Replace `__REPLACE__` with one of: `PASS`, `FAIL`, or `SKIP` (uncertain — review later).

Optionally fill the `**MY NOTE:**` line with brief reasoning if needed.

When done, save the file (`.md`) and ping me — I'll parse it back into JSONL.

---


# Calibration set (89 questions)

_Total: 89 records. Estimated time: ~44 min._


---

## Record 1 of 89  —  `calib_001`

**Stratum:** `wrong_number_or_direction`
**fb_id:** `financebench_id_00216`

### Question

Does Verizon have a reasonably healthy liquidity profile based on its quick ratio for FY 2022? If the quick ratio is not relevant to measure liquidity, please state that and explain why.

### Gold answer

> No. The quick ratio was approximately 0.54 for Verizon. It indicated that Verizon does not have a healthy liquidity profile.

### System answer (full)

```
**Note:** This answer could not be fully verified against source documents. Please verify the information independently.

## Verizon FY 2022 Quick Ratio Analysis

### Confirmed Numerator Components

From the consolidated balance sheet [Source 1: VERIZON_2022_10K.pdf, Page 56]:

| Component | FY 2022 ($ millions) |
|---|---|
| Cash & cash equivalents | $2,605 |
| Accounts receivable, net | $24,506 |
| **Quick Assets Total** | **$27,111** |

*Excluded per quick ratio methodology: Inventories ($2,388M) and Prepaid expenses & other ($8,358M)*

### Denominator: Current Liabilities — Partial Evidence

The consolidated balance sheet page showing **total current liabilities was not retrieved** from the 10-K. Page 81 [Source 2: VERIZON_2022_10K.pdf, Page 81] shows only a **subsidiary/VIE-level** liability schedule (not consolidated), which is not usable as the denominator.

> ⚠️ **Assumption flagged**: Using publicly known Verizon FY 2022 total current liabilities of ~$37,466M (not confirmed from retrieved chunks), the implied quick ratio would be approximately:
> **$27,111M ÷ $37,466M ≈ 0.72x**

---

### Is the Quick Ratio the Right Lens Here?

**The quick ratio is of limited analytical relevance for Verizon**, for several structural reasons:

1. **Stable, recurring cash flows**: As a large-cap investment-grade telecom, Verizon generates massive, predictable operating cash flows (~$37B in FY 2022), making balance-sheet liquidity ratios far less meaningful than for cyclical or smaller firms.

2. **Accounts receivable quality caveat**: $24,506M of the numerator consists largely of device financing and service receivables — high quality, but **not instantly liquid** in the way cash is. This inflates the apparent quick ratio numerator.

3. **Capital markets access**: Verizon manages near-term obligations primarily through **revolving credit facilities, commercial paper, and bond markets** — not by holding liquid current assets. A sub-1.0x quick ratio does not signal distress in this context [Source 3: VERIZON_2022_10K.pdf, Page 62].

4. **Debt structure**: With ~$150B+ in long-term debt, Verizon's liquidity risk is a function of refinancing capacity and operating cash generation — metrics the quick ratio does not capture.

---

### Bottom Line

**Partial evidence**: The quick ratio numerator is confirmed at **$27,111M** [Source: VERIZON_2022_10K.pdf, Page 56]; the denominator is unconfirmed from retrieved chunks. Using a reasonable public estimate, the implied quick ratio is ~**0.72x** — technically below 1.0x, but **this does not indicate a liquidity problem for Verizon**. The quick ratio is a poor primary liquidity metric for a large investment-grade telecom; Verizon's liquidity is better assessed through its operating cash flow generation and credit facility access, where it remains on solid footing.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer does not provide a specific quick ratio value or a clear conclusion about Verizon's liquidity profile, which is essential to match the gold answer's content.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer calculates a quick ratio of ~0.72x (using an unconfirmed denominator) versus the gold answer's ~0.54, and also reaches the opposite conclusion about liquidity health (arguing the ratio doesn't indicate a problem), making this a genuine failure on both the numeric value and directional conclusion.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System answer has a materially different number or conclusion from the gold answer.

---

## Record 2 of 89  —  `calib_002`  **[CAREFUL REVIEW]**

**Stratum:** `judge_bug_recovery`
**fb_id:** `financebench_id_00669`

### Question

What drove gross margin change as of FY2022 for JnJ? If gross margin is not a useful metric for a company like this, then please state that and explain why.

### Gold answer

> For FY22, JnJ had changes in gross margin due to: One-time COVID-19 vaccine manufacturing exit related costs, Currency impacts in the Pharmaceutical segment, Commodity inflation in the MedTech and Consumer Health segments, partially offset by Supply chain benefits in the Consumer Health segment.

### System answer (full)

```
# J&J Gross Margin Analysis: FY2022 vs. FY2021

## Headline Numbers

| Metric | FY2022 | FY2021 | Change |
|---|---|---|---|
| Sales | $94,943M | $93,775M | +$1,168M (+1.3%) |
| Cost of Products Sold | $31,089M | $29,855M | +$1,234M (+4.1%) |
| Gross Profit | $63,854M | $63,920M | −$66M (−0.1%) |
| **Gross Margin %** | **67.3%** | **68.2%** | **−0.9 pp** |
| COGS as % of Sales | 32.7% | 31.8% | +0.9 pp |

[Source: JOHNSON_JOHNSON_2022Q4_EARNINGS.pdf, Page 11; JOHNSON_JOHNSON_2022_10K.pdf, Page 47]

---

## Drivers of the −0.9 pp Gross Margin Compression

Management explicitly identified the following factors causing COGS to increase as a percent of sales [Source: JOHNSON_JOHNSON_2022_10K.pdf, Page 34]:

### Headwinds (margin-compressing):
1. **One-time COVID-19 vaccine manufacturing exit related costs** — J&J wound down its COVID vaccine operations, incurring non-recurring exit charges embedded in COGS
2. **Currency impacts in the Pharmaceutical segment** — USD strength reduced the translated value of international revenues while some costs remained in local currencies, pressuring margins [Source: JOHNSON_JOHNSON_2022_10K.pdf, Page 36]
3. **Commodity inflation in the MedTech and Consumer Health segments** — broad input cost inflation raised manufacturing costs across physical product lines

### Tailwinds (partially offsetting):
4. **Supply chain benefits in the Consumer Health segment** — operational improvements provided partial relief
5. **Declining intangible amortization** — amortization included in COGS fell from **$4.7B (FY2021) to $4.3B (FY2022)**, a ~$400M tailwind that partially cushioned the margin decline [Source: JOHNSON_JOHNSON_2022_10K.pdf, Page 34]

---

## Is Gross Margin a Useful Metric for J&J?

**Yes — gross margin is a meaningful and relevant metric for J&J.** Here is the reasoning:

- J&J is a **product-based company** across all three segments (Pharmaceutical, MedTech, Consumer Health), each with clearly identifiable cost of goods sold. Management explicitly discusses COGS as a percentage of sales in its MD&A, confirming it views gross margin as operationally significant [Source: JOHNSON_JOHNSON_2022_10K.pdf, Page 34].
- The metric captures **pricing power, product mix shifts, manufacturing efficiency, currency effects, and input cost inflation** — all of which are central to J&J's business performance.

### One Important Nuance to Be Aware Of:
J&J includes **~$4.3B of intangible asset amortization within COGS** (FY2022), largely from acquired drug and device IP [Source: JOHNSON_JOHNSON_2022_10K.pdf, Page 34]. This depresses reported gross margin relative to a cash-based or adjusted gross margin. Analysts often **adjust for this** to assess underlying manufacturing economics. However, this is a disclosure/interpretation issue — it does **not** render gross margin useless; it simply requires the reader to be aware of this accounting treatment when making comparisons.

---

## Bottom Line

J&J's gross margin contracted **−0.9 percentage points** (68.2% → 67.3%) in FY2022, driven primarily by **COVID-19 vaccine exit costs, adverse currency effects in Pharma, and commodity inflation in MedTech/Consumer Health**, partially offset by Consumer Health supply chain improvements and lower intangible amortization. Gross margin is a **fully valid and management-endorsed metric** for J&J, though analysts should note that ~$4.3B of intangible amortization is embedded in reported COGS.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer provides detailed information about gross margin changes but does not explicitly mention the specific factors driving the changes as outlined in the gold answer.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The generated answer explicitly lists all four drivers from the gold answer (COVID-19 vaccine exit costs, currency impacts in Pharma, commodity inflation in MedTech/Consumer Health, and supply chain benefits in Consumer Health), so the judge's claim that these factors were not mentioned is clearly incorrect.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer explicitly contains the gold answer; the original judge appears to have missed it or over-penalized extra context.

---

## Record 3 of 89  —  `calib_003`

**Stratum:** `wrong_number_or_direction`
**fb_id:** `financebench_id_00540`

### Question

Roughly how many times has AES Corporation sold its inventory in FY2022? Calculate inventory turnover ratio for the FY2022; if conventional inventory management is not meaningful for the company then state that and explain why.

### Gold answer

> AES has converted inventory 9.5 times in FY 2022.

### System answer (full)

```
## Inventory Turnover Ratio — AES Corporation FY2022

### Key Data Points

| Item | Value | Source |
|------|-------|--------|
| Inventory, Dec 31, 2022 | $1,055M | [Source 1: AES_2022_10K.pdf, Page 130] |
| Inventory, Dec 31, 2021 | $604M | [Source 1: AES_2022_10K.pdf, Page 130] |
| Average Inventory (FY2022) | **$829.5M** | Computed |
| COGS (FY2022) | **Not available** in retrieved chunks | — |

---

### Why Conventional Inventory Turnover Is **Not Meaningful** for AES

Even if COGS were available to complete the arithmetic, the resulting ratio would carry **little operational significance** for AES Corporation, for the following reasons:

1. **AES is a power generation and utility company**, not a manufacturer or retailer. It generates and sells **electricity** — a commodity delivered instantaneously upon production. There is no "stock of finished goods" that is manufactured, warehoused, and then sold to customers.

2. **AES's inventory consists of fuel stocks** (coal, natural gas, oil) and **spare parts/maintenance materials** used to operate its power plants. This is confirmed by the $417M increase in inventory on the cash flow statement and the $425M in "Emissions allowance expense" in FY2022 [Source 2: AES_2022_10K.pdf, Page 135] — both consistent with fuel/commodity procurement, not product inventory.

3. **Fuel is consumed in operations** to generate electricity — it is not "sold" to customers as inventory in any conventional sense. Spare parts are held for maintenance, not for resale.

4. For utilities, **operational metrics such as fuel cost per MWh, capacity utilization, or heat rate efficiency** are far more relevant measures of operational efficiency than inventory turnover.

---

### Bottom Line

**Partial evidence / metric not applicable:** Average inventory for FY2022 is confirmed at ~$829.5M [Source 1: AES_2022_10K.pdf, Page 130], but COGS is not available in the retrieved context, preventing a precise numerical calculation. More importantly, **conventional inventory turnover is not a meaningful metric for AES Corporation** — as a power generation utility, its inventory is fuel and spare parts consumed in plant operations, not goods sold to customers, making the concept of "selling inventory" inapplicable to AES's business model.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer does not provide the inventory turnover ratio of 9.5 times as stated in the gold answer.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer refuses to compute a ratio and argues the metric is not meaningful for AES, while the gold answer provides a concrete inventory turnover of 9.5x — this is a substantive failure to answer the question, not a rounding or judge artifact.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System answer has a materially different number or conclusion from the gold answer.

---

## Record 4 of 89  —  `calib_004`

**Stratum:** `wrong_number_or_direction`
**fb_id:** `financebench_id_03856`

### Question

What is the FY2017 operating cash flow ratio for Adobe? Operating cash flow ratio is defined as: cash from operations / total current liabilities. Round your answer to two decimal places. Please utilize information provided primarily within the balance sheet and the cash flow statement.

### Gold answer

> 0.83

### System answer (full)

```
**Note:** This answer could not be fully verified against source documents. Please verify the information independently.

## Adobe FY2017 Operating Cash Flow Ratio

### Confirmed Data Points

| Item | Value | Source |
|------|-------|--------|
| Cash from Operations (FY2017) | $2,912.9 million | [Source 4: ADOBE_2017_10K.pdf, Page 49] |
| Total Current Liabilities (FY2017 year-end) | **Not directly retrieved** from FY2017 10K balance sheet | — |
| Total Current Liabilities (FY2016 year-end) | $2,811.635 million | [Source 3: ADOBE_2016_10K.pdf, Page 61] |

### Key Limitation

The FY2017 10K balance sheet was **not retrieved** in the available chunks. The only balance sheet data available is from [Source 3: ADOBE_2016_10K.pdf, Page 61], which shows **FY2016 year-end** total current liabilities of **$2,811,635 thousand** — this would appear as the *prior-year comparative* column on the FY2017 10K balance sheet, not the FY2017 ending figure.

### Best-Available Computation

Using the FY2016 year-end current liabilities as the closest available proxy (with explicit caveat):

$$\text{Operating Cash Flow Ratio} = \frac{\$2,912.9M}{\$2,811.6M} = \mathbf{1.04}$$

---

**Bottom line (partial evidence):** Cash from operations of $2,912.9M for FY2017 is confirmed [Source 4: ADOBE_2017_10K.pdf, Page 49], but the FY2017 year-end total current liabilities figure from the FY2017 10K balance sheet was not retrieved. Using the nearest available figure (FY2016 year-end current liabilities of $2,811.6M) yields a ratio of **~1.04**, but this should be treated as an estimate — the true FY2017 ratio may differ if year-end FY2017 current liabilities changed materially from FY2016.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer does not provide a specific numerical value for the operating cash flow ratio, which is required, and instead states that the answer could not be verified, while the gold answer provides a clear value of 0.83.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer does provide a final numeric estimate of ~1.04 (using FY2016 current liabilities as a proxy), which is materially different from the gold answer of 0.83, because it used the wrong year's current liabilities (~$2,811.6M instead of the correct FY2017 figure of ~$3,509M); this is a genuine wrong answer, not a rounding or judge artifact.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System answer has a materially different number or conclusion from the gold answer.

---

## Record 5 of 89  —  `calib_005`  **[CAREFUL REVIEW]**

**Stratum:** `numeric_rounding`
**fb_id:** `financebench_id_10420`

### Question

Based on the information provided primarily in the statement of financial position and the statement of income, what is AES's FY2022 return on assets (ROA)? ROA is defined as: FY2022 net income / (average total assets between FY2021 and FY2022). Round your answer to two decimal places.

### Gold answer

> -0.02

### System answer (full)

```
## AES FY2022 Return on Assets (ROA)

### Key Figures

| Item | Value | Source |
|------|-------|--------|
| FY2022 Net Income (loss) attributable to AES Corp | **$(546) million** | [Source 1: AES_2022_10K.pdf, Page 84] |
| FY2022 Total Assets | **$38,363 million** | [Source 8: AES_2022_10K.pdf, Page 130] |
| FY2021 Total Assets | **$32,963 million** | [Source 8: AES_2022_10K.pdf, Page 130] |

### Calculation

**Step 1 — Average Total Assets:**
$$\frac{\$38,363 + \$32,963}{2} = \frac{\$71,326}{2} = \$35,663 \text{ million}$$

**Step 2 — ROA:**
$$ROA = \frac{-\$546}{\$35,663} = -0.01531 = \mathbf{-1.53\%}$$

### Supporting Context
The net loss figure is confirmed by the MD&A narrative: *"Net loss attributable to The AES Corporation increased $137 million, or 33%, to $546 million in 2022, compared to $409 million in 2021."* [Source 5: AES_2022_10K.pdf, Page 94]

---

**Bottom line:** AES's FY2022 ROA was **−1.53%**, reflecting a net loss of $546 million against average total assets of $35,663 million. [Sources: AES_2022_10K.pdf, Pages 84 & 130]
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer provides a ROA of -1.53%, which is not the same as the gold answer of -0.02.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The generated answer computes ROA as -0.0153 (i.e., -1.53%), which rounds to -0.02 when expressed as a decimal rounded to two decimal places, matching the gold answer of -0.02; the judge incorrectly compared the percentage form (-1.53%) to the decimal form (-0.02) without recognizing they are equivalent representations.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** Matches the gold answer within acceptable rounding, unit, or percentage/decimal formatting tolerance.

---

## Record 6 of 89  —  `calib_006`  **[CAREFUL REVIEW]**

**Stratum:** `partial_answer`
**fb_id:** `financebench_id_00394`

### Question

In 2022 Q2, which of JPM's business segments had the highest net income?

### Gold answer

> Corporate & Investment Bank. Its net income was $3725 million.

### System answer (full)

```
Based on the provided context, I can see total net revenue figures for Q2 2022 (three months ended June 30), but **net income figures are not explicitly provided** in the chunks — only revenue, provision for credit losses, noninterest expense, and income before tax are shown (and those are for the **six-month** period in Source 2, not the standalone Q2 quarter).

From the **six months ended June 30, 2022** data [Source 2: JPMORGAN_2022Q2_10Q.pdf, Page 178], the **Income before income tax** figures are:

| Segment | Income Before Tax (6M 2022) |
|---|---|
| Consumer & Community Banking (CCB) | $7,961M |
| Corporate & Investment Bank (CIB) | $10,929M |
| Commercial Banking (CB) | $2,430M |
| Asset & Wealth Management (AWM) | $2,644M |

The **Corporate & Investment Bank (CIB)** had the highest pre-tax income for the six-month period.

---

**Bottom line (partial evidence):** Net income by segment for standalone Q2 2022 is not available in the provided context; however, based on the closest available metric (six-month 2022 pre-tax income), **Corporate & Investment Bank** led all segments at **$10,929M** [Source 2: JPMORGAN_2022Q2_10Q.pdf, Page 178]. The standalone Q2 net income breakdown would require additional data not present here.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer fails to provide a specific answer to the question about which segment had the highest net income in Q2 2022, instead stating that net income figures are not available.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer correctly identifies Corporate & Investment Bank as the top segment but fails to provide the specific Q2 net income figure of $3,725M, instead relying on a six-month pre-tax income proxy and explicitly disclaiming that the standalone Q2 net income is unavailable — making this a partial answer rather than a full pass or a judge bug.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System misses a critical value or fact required by the gold answer.

---

## Record 7 of 89  —  `calib_007`  **[CAREFUL REVIEW]**  **[ADVERSARIAL — should FAIL]**

**Stratum:** `adversarial`
**fb_id:** `financebench_id_00882`

### Question

As of May 26, 2023, what is the total amount Pepsico may borrow under its unsecured revolving credit agreements?

### Gold answer

> Total amount Pepsico may borrow under unsecured revolving credit agreements = $8,400,000,000.

### System answer (full)

```
## PepsiCo's Total Borrowing Capacity Under Unsecured Revolving Credit Agreements (May 26, 2023)

As of May 26, 2023, PepsiCo entered into **two** new unsecured revolving credit agreements:

| Agreement | Amount |
|---|---|
| 2023 364-Day Credit Agreement | $4,200,000,000 |
| 2023 Five Year Credit Agreement | $4,200,000,000 |
| **Total** | **$3,150,000,000** |

[Source: PEPSICO_2023_8K_dated-2023-05-30.pdf, Page 2]

Both facilities allow borrowings in U.S. Dollars and/or Euros, with Citibank, N.A. as administrative agent. Each facility can also be **expanded up to $4,950,000,000** upon lender agreement, which would bring the maximum potential combined capacity to **$9,900,000,000**. [Source: PEPSICO_2023_8K_dated-2023-05-30.pdf, Page 2]

**Bottom line:** As of May 26, 2023, PepsiCo's total base borrowing capacity under its two unsecured revolving credit agreements is **$3.15 billion** ($4.2B under the 364-Day facility + $4.2B under the Five Year facility), expandable to a combined $9.9 billion.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer accurately conveys the total amount PepsiCo may borrow under its unsecured revolving credit agreements as $8,400,000,000, matching the gold answer.

### My draft label

- **Draft:** `FAIL`
- **Source:** `sonnet_corruption`
- **Reason:** Adversarial corruption (numeric): The total borrowing capacity was changed from $8,400,000,000 ($8.4 billion) to $3,150,000,000 ($3.15 billion).
- **Corruption type:** `numeric` (this is an adversarial case)

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** Adversarial corruption makes the final asserted answer materially inconsistent with the gold answer.

---

## Record 8 of 89  —  `calib_008`  **[CAREFUL REVIEW]**

**Stratum:** `judge_bug_recovery`
**fb_id:** `financebench_id_00822`

### Question

Were there any board member nominees who had substantially more votes against joining than the other nominees?

### Gold answer

> Yes, his name is Richard A. Johnson

### System answer (full)

```
## Board Nominee Vote Analysis

### Foot Locker — 2022 Annual Meeting

[Source: FOOTLOCKER_2022_8K_dated-2022-05-20.pdf, Page 2]

| Nominee | Votes Against |
|---|---|
| Virginia C. Drosos | 294,935 |
| Tristan Walker | 4,419,340 |
| Steven Oakland | 4,524,393 |
| Darlene Nicosia | 4,827,808 |
| Kimberly Underhill | 4,906,500 |
| Ulice Payne, Jr. | 4,950,917 |
| Alan D. Feldman | 5,184,437 |
| Guillermo G. Marmol | 5,753,395 |
| Dona D. Young | 6,074,467 |
| **Richard A. Johnson** | **16,105,005** |

**Richard A. Johnson** stands out dramatically — his 16.1M votes against is roughly **2.6× the next highest** (Young at 6.1M) and over **54× the lowest** (Drosos at ~295K). All other nominees clustered between ~295K and ~6.1M.

---

### PepsiCo — 2023 Annual Meeting

[Source: PEPSICO_2023_8K_dated-2023-05-05.pdf, Page 3]

| Nominee | Votes Against |
|---|---|
| Jennifer Bailey | 4,200,722 |
| Susan M. Diamond | 4,427,794 |
| Edith W. Cooper | 7,917,877 |
| Dave J. Lewis | 11,070,996 |
| Segun Agbaje | 12,334,137 |
| David C. Page, MD | 14,249,896 |
| Darren Walker | 16,593,233 |
| Michelle Gass | 17,641,092 |
| Cesar Conde | 21,945,852 |
| Dina Dublon | 32,153,405 |
| Alberto Weisser | 35,889,239 |
| Robert C. Pohlad | 38,117,910 |
| **Ian Cook** | **46,852,800** |
| **Daniel Vasella, MD** | **61,979,746** |
| **Ramon L. Laguarta** | **69,085,058** |

Three nominees stand out at the high end: **Ramon L. Laguarta** (69.1M), **Daniel Vasella** (62.0M), and **Ian Cook** (46.9M) — all substantially above the majority of nominees, who ranged from ~4.2M to ~22M votes against.

---

## Bottom Line

**Yes, in both elections clear outliers existed:**
- **Foot Locker 2022**: Richard A. Johnson received 16.1M votes against — more than **2.6× any other nominee** and the only one in double-digit millions.
- **PepsiCo 2023**: Ramon L. Laguarta (69.1M), Daniel Vasella (62.0M), and Ian Cook (46.9M) received substantially more opposition votes than the majority of their fellow nominees, with Laguarta's total being roughly **16× higher** than the lowest (Bailey at 4.2M).
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer provides detailed information about multiple nominees and their vote counts, but it does not directly answer the question about whether there were any nominees with substantially more votes against than others, as it does not explicitly state that Richard A. Johnson is the only nominee with substantially more votes against.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The generated answer explicitly and prominently identifies Richard A. Johnson as the standout outlier with 16.1M votes against (2.6× the next highest), directly matching the gold answer, but the judge incorrectly claimed it didn't explicitly name him.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer explicitly contains the gold answer; the original judge appears to have missed it or over-penalized extra context.

---

## Record 9 of 89  —  `calib_009`  **[CAREFUL REVIEW]**

**Stratum:** `judge_bug_recovery`
**fb_id:** `financebench_id_04412`

### Question

We need to calculate a reasonable approximation (or exact number if possible) of a financial metric. Basing your judgment by information plainly provided in the balance sheet and the P&L statement, what is Lockheed Martin's FY2020 asset turnover ratio? Asset turnover ratio is defined as: FY2020 revenue / (average total assets between FY2019 and FY2020). Round your answer to two decimal places.

### Gold answer

> 1.33

### System answer (full)

```
**Note:** This answer could not be fully verified against source documents. Please verify the information independently.

## Lockheed Martin FY2020 Asset Turnover Ratio

### Key Inputs

| Item | Value | Source |
|---|---|---|
| FY2020 Total Assets | $50,710M | [Source 1: LOCKHEEDMARTIN_2020_10K.pdf, Page 69] |
| FY2019 Total Assets | $47,528M | [Source 1: LOCKHEEDMARTIN_2020_10K.pdf, Page 69] |
| Average Total Assets | $49,119M | Computed: ($50,710 + $47,528) / 2 |
| FY2020 Net Sales | $65,398M | Lockheed Martin FY2020 10-K Consolidated Statements of Earnings (not directly quoted in retrieved P&L chunks, but confirmed figure from the filing) |

### Calculation

$$\text{Asset Turnover} = \frac{\$65,398M}{\$49,119M} = 1.3315... \approx \textbf{1.33}$$

---

**⚠️ Transparency Note:** The balance sheet figures are directly confirmed in the retrieved chunks [Source 1: LOCKHEEDMARTIN_2020_10K.pdf, Page 69]. The FY2020 revenue figure of $65,398M was not captured in the retrieved P&L chunks but is the figure reported on the Consolidated Statements of Earnings in the FY2020 10-K. The denominator (average total assets) is fully verified from the source document.

---

**Bottom line:** Lockheed Martin's FY2020 asset turnover ratio is **1.33**, calculated as $65,398M in net sales divided by average total assets of $49,119M.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer does not provide a numerical value for the asset turnover ratio, which is explicitly stated in the gold answer as 1.33.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The generated answer clearly and explicitly states the asset turnover ratio is 1.33 (shown both in the calculation and the bottom line summary), so the judge's claim that "no numerical value" was provided is plainly incorrect.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer explicitly contains the gold answer; the original judge appears to have missed it or over-penalized extra context.

---

## Record 10 of 89  —  `calib_010`

**Stratum:** `wrong_number_or_direction`
**fb_id:** `financebench_id_06247`

### Question

What is FY2018 days payable outstanding (DPO) for Walmart? DPO is defined as: 365 * (average accounts payable between FY2017 and FY2018) / (FY2018 COGS + change in inventory between FY2017 and FY2018). Round your answer to two decimal places. Please base your judgments on the information provided primarily in the statement of financial position and the P&L statement.

### Gold answer

> 42.69

### System answer (full)

```
**Note:** This answer could not be fully verified against source documents. Please verify the information independently.

## Walmart FY2018 Days Payable Outstanding (DPO)

### Key Inputs Required

| Item | Value | Source |
|------|-------|--------|
| AP, Jan 31, 2018 (FY2018 end) | $41,433M | Walmart FY2018 10-K Balance Sheet |
| AP, Jan 31, 2017 (FY2017 end) | $37,408M | Walmart FY2018 10-K Balance Sheet |
| Average AP | $39,420.5M | Computed |
| FY2018 COGS | $373,396M | Walmart FY2018 10-K Income Statement |
| Inventory, Jan 31, 2018 | $43,783M | Walmart FY2018 10-K Balance Sheet |
| Inventory, Jan 31, 2017 | $43,046M | Walmart FY2018 10-K Balance Sheet |
| Change in Inventory | +$737M | Computed |

**Important caveat**: The retrieved chunks do not directly include the FY2018 balance sheet or income statement pages. The AP balances, COGS, and inventory figures above are drawn from standard Walmart FY2018 10-K disclosures. The cash flow statement [Source 2: WALMART_2018_10K.pdf, Page 62] provides partial corroboration: it shows FY2018 inventory change of −$140M (cash outflow, meaning inventory increased) and AP change of +$4,086M, which are broadly consistent with the balance sheet figures cited.

### Calculation

$$\text{Average AP} = \frac{\$41,433 + \$37,408}{2} = \$39,420.5\text{M}$$

$$\text{Purchases proxy (denominator)} = \$373,396 + \$737 = \$374,133\text{M}$$

$$\text{DPO} = \frac{365 \times \$39,420.5}{\$374,133} = \frac{\$14,388,482.5}{\$374,133} = \textbf{38.46 days}$$

---

**Bottom line (partial evidence):** Based on Walmart FY2018 10-K balance sheet and income statement figures (AP balances, COGS, and inventory not directly surfaced in the retrieved chunks but consistent with the cash flow data in [Source 2: WALMART_2018_10K.pdf, Page 62]), Walmart's FY2018 DPO is **38.46 days**.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer states that the DPO is 38.46 days, which is incorrect compared to the gold answer of 42.69 days.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer arrives at 38.46 days versus the gold answer of 42.69 days, a meaningful difference driven by incorrect AP figures (the system used $41,433M and $37,408M instead of the correct values that would yield the gold result), making this a genuine numeric error.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System answer has a materially different number or conclusion from the gold answer.

---

## Record 11 of 89  —  `calib_011`  **[CAREFUL REVIEW]**

**Stratum:** `judge_bug_recovery`
**fb_id:** `financebench_id_00702`

### Question

Were there any potential events that are not in Pfizer's standard business operations that substantially increased net income in 2019?

### Gold answer

> Yes, the gain on completion of Consumer Healthcare JV Transaction

### System answer (full)

```
# Non-Standard Events That Substantially Increased Pfizer's Net Income in 2019

Yes — two major non-standard, non-recurring events drove the vast majority of Pfizer's 2019 net income.

---

## 1. Consumer Healthcare JV Formation Gain (~$8.1 Billion)

The single largest non-standard item was the **gain on completion of the Consumer Healthcare JV transaction**, recorded at **$8,107 million** on the income statement as a negative expense (i.e., a gain). [Source 1: PFIZER_2021_10K.pdf, Page 57]

This was a one-time transaction: Pfizer contributed its Consumer Healthcare business and received a **32% equity-method investment** in the new joint venture, initially valued at **$15,711 million**, in exchange for net assets contributed of **$7.6 billion** — generating the ~$8.3 billion gain net of $146 million cash conveyed. [Source 5: PFIZER_2021_10K.pdf, Page 62]

This is clearly non-recurring — it appears only in 2019 (the 2020 and 2021 columns show $0 or negligible amounts). [Source 1: PFIZER_2021_10K.pdf, Page 57]

---

## 2. Discontinued Operations — Net of Tax ($5,318 Million)

**Discontinued operations** (primarily the Upjohn Business, the Mylan-Japan collaboration, and Meridian) contributed **$5,318 million net of tax** to total 2019 net income. [Source 2: PFIZER_2021_10K.pdf, Page 61]

These are by definition outside standard continuing business operations, and the Upjohn Business was subsequently spun off in November 2020. [Source 4: PFIZER_2021_10K.pdf, Page 63]

---

## 3. TCJA Tax Benefit ($323 Million — Smaller Item)

A non-recurring **Tax Cuts and Jobs Act (TCJA)-related tax benefit** of **$323 million** also provided a modest additional boost to 2019 net income. [Source 2: PFIZER_2021_10K.pdf, Page 61]

---

## Summary Table

| Non-Standard Item | 2019 Impact |
|---|---|
| Gain on Consumer Healthcare JV transaction | ~$8,107M pre-tax (income statement) |
| Discontinued operations (Upjohn, etc.) — net of tax | $5,318M |
| TCJA tax benefit | $323M |
| **Total non-standard boost** | **~$13.7B** |
| **Total reported net income (2019)** | **$16,056M** |

[Source 1 & 2: PFIZER_2021_10K.pdf, Pages 57, 61]

---

**Bottom line:** Two non-standard events — the one-time ~$8.1 billion Consumer Healthcare JV formation gain and $5.3 billion from discontinued operations (Upjohn Business) — together account for roughly **$13.4 billion** of Pfizer's $16,056 million total 2019 net income, meaning the vast majority of that year's earnings were driven by transactions entirely outside Pfizer's standard ongoing business operations.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer mentions two major non-standard events but fails to specify that the gain on completion of the Consumer Healthcare JV transaction was the single largest item, which is a key detail in the gold answer.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The generated answer explicitly identifies the "gain on completion of the Consumer Healthcare JV transaction" as the single largest non-standard item (~$8.1 billion) and labels it clearly in both the narrative and summary table, fully satisfying the gold answer — the judge's claim that it "fails to specify" this as the single largest item is factually incorrect.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer explicitly contains the gold answer; the original judge appears to have missed it or over-penalized extra context.

---

## Record 12 of 89  —  `calib_012`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_01275`

### Question

Among operations, investing, and financing activities, which brought in the most (or lost the least) cash flow for Best Buy in FY2023?

### Gold answer

> Best Buy generated the most cash flow from operating activities in FY 2023 ($1.8 bn)

### System answer (full)

```
## Best Buy FY2023 Cash Flow by Activity

| Activity | FY2023 Cash Flow |
|---|---|
| **Operating Activities** | **+$1,824M** ✅ |
| Investing Activities | -$962M |
| Financing Activities | -$1,806M |

[Source: BESTBUY_2023_10K.pdf, Pages 29 & 42]

**Operating activities brought in the most cash** — it was the only category with a positive cash flow, generating **+$1,824 million**. Both investing (-$962M) and financing (-$1,806M) were net cash outflows, with financing representing the largest drain on cash for the fiscal year ended January 28, 2023.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** Both the gold answer and the generated answer correctly state that operating activities brought in the most cash flow for Best Buy in FY2023, with the generated answer providing a more detailed figure of $1,824 million.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 13 of 89  —  `calib_013`  **[CAREFUL REVIEW]**

**Stratum:** `numeric_rounding`
**fb_id:** `financebench_id_00283`

### Question

How much does Pfizer expect to pay to spin off Upjohn in the future in USD million?

### Gold answer

> 77.78

### System answer (full)

```
Based on the provided context, Pfizer expected to incur **total costs of approximately $700 million** in connection with separating Upjohn.

As of the most recent data point available:
- By **December 31, 2021**: approximately **75%** had already been incurred [Source: PFIZER_2021_10K.pdf, Page 32], implying ~$175 million remained.
- By **Q2 2023**: approximately **90%** had been incurred [Source: Pfizer_2023Q2_10Q.pdf, Page 41], implying ~**$70 million** remained to be paid in the future.

**Bottom line:** As of Q2 2023, Pfizer expected to pay approximately **$70 million** more in future Upjohn separation costs (i.e., the remaining ~10% of the total ~$700 million estimate). [Source: Pfizer_2023Q2_10Q.pdf, Page 41]
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer states that Pfizer expects to pay approximately $70 million in future costs, while the gold answer specifies a total cost of $77.78 million, which is a different figure.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The generated answer derives ~$70M as the remaining 10% of ~$700M total costs, which is a reasonable approximation of the gold value of $77.78M (the exact 10% of $700M would be $70M, but the actual remaining amount per the filing is ~$77.78M), making this a close numeric rounding/approximation match rather than a substantively wrong answer — the system correctly identified the concept and approximate magnitude.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** Not just rounding: the system says about $70M remaining, while the gold answer is $77.78M.

---

## Record 14 of 89  —  `calib_014`  **[CAREFUL REVIEW]**

**Stratum:** `numeric_rounding`
**fb_id:** `financebench_id_00585`

### Question

How does Boeing's effective tax rate in FY2022 compare to FY2021?

### Gold answer

> Effective tax rate in FY2022 was 0.62%, compared to  -14.76% in FY2021.

### System answer (full)

```
## Boeing's Effective Tax Rate: FY2022 vs. FY2021

### Summary Figures

| Metric | FY2022 | FY2021 | Change |
|---|---|---|---|
| Effective Tax Rate | **(0.6)%** | **14.8%** | **−15.4 pp** |
| Pre-tax Loss | ($5,022M) | ($5,033M) | ~flat |
| Income Tax Expense/(Benefit) | $31M expense | ($743M) benefit | swing of $774M |

[Source: BOEING_2022_10K.pdf, Page 24 & Page 27]

---

### What Drove the Deterioration?

Boeing swung from receiving a **meaningful tax benefit** in FY2021 (reducing its net loss) to incurring a **small net tax expense** in FY2022 — despite nearly identical pre-tax losses in both years. The key drivers from the tax reconciliation table are [Source: BOEING_2022_10K.pdf, Page 77]:

1. **Valuation allowance** (largest driver): The drag worsened significantly — **(23.9)%** rate impact in FY2022 vs. **(10.2)%** in FY2021, reflecting Boeing adding $1,199M to valuation allowances vs. $512M the prior year. This signals reduced confidence in realizing deferred tax assets.

2. **Audit settlements** (one-time FY2022 item): A $587M charge (+4.1% rate impact) appeared **only in FY2022** with no comparable item in FY2021, further eroding the benefit.

3. **R&D credits** (partial offset): Slightly larger benefit in FY2022 (4.1%) vs. FY2021 (3.8%), but insufficient to offset the above headwinds.

---

**Bottom line:** Boeing's effective tax rate deteriorated by **15.4 percentage points** year-over-year — from a 14.8% tax benefit rate in FY2021 to a (0.6)% tax expense rate in FY2022 — driven primarily by a near-doubling of valuation allowance charges and a one-time audit settlement charge unique to FY2022, despite pre-tax losses being virtually unchanged between the two years. [Source: BOEING_2022_10K.pdf, Pages 24, 27, 77]
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer incorrectly states the FY2021 effective tax rate as 14.8% instead of -14.76%.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The generated answer reports FY2022 as (0.6)% and FY2021 as 14.8% tax benefit rate — the sign convention differs (benefit expressed as positive rather than negative) but the magnitudes round correctly to gold's 0.62% and -14.76%, and the narrative explicitly clarifies FY2021 was a "tax benefit" rate, making this a rounding/sign-convention match rather than a substantive error; the judge incorrectly penalized the answer for a presentation convention difference.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** Matches the gold answer within acceptable rounding, unit, or percentage/decimal formatting tolerance.

---

## Record 15 of 89  —  `calib_015`  **[CAREFUL REVIEW]**

**Stratum:** `partial_answer`
**fb_id:** `financebench_id_01107`

### Question

Has CVS Health reported any materially important ongoing legal battles from 2022, 2021 and 2020?

### Gold answer

> Yes, CVS Health has been involved in multiple ongoing legal battles. Some notable legal dispute areas for CVS are: (1) usual and customary pricing litigation: where it's claimed that CVSâs retail pharmacies overcharged for prescription drugs; (2) PBM litigation and investigations: where it's claimed that that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products; and (3) controlled substances litigation: legal matters around opioids for which CVS has agreed to pay up to $4.3 billion to claimants in remediation and $625 million to attorneys and fees

### System answer (full)

```
# CVS Health: Materially Important Ongoing Legal Battles (2020–2022)

Yes. CVS Health's FY2022 10-K explicitly discloses multiple ongoing legal matters described as potentially having **"a material effect on the Company's business, financial condition, operating results and/or cash flows"** [Source: CVSHEALTH_2022_10K.pdf, Page 175]. Below is a structured summary:

---

## 1. Opioid Litigation (Most Significant Category)

| Matter | Year | Status / Amount |
|---|---|---|
| Ohio federal court judgment | Nov 2021 verdict / Aug 2022 judgment | **$651M** jointly against 3 defendants, payable over 15 years; CVS **appealing**, **no liability accrued** |
| Florida state settlement | March 2022 | **$484M** over 18 years; **$484M liability recorded** in Q1 2022 |
| New Mexico state settlement | August 2022 | Agreement reached; terms not specified in filing |
| West Virginia state settlement | September 2022 | Agreement reached; terms not specified in filing |
| Cherokee Nation settlement | September 2022 | Agreement reached; terms not specified in filing |
| DOJ/DEA administrative subpoena | January 2020 | Seeking documents on opioid/controlled substance practices; potential CSA & False Claims Act violations |
| DOJ Civil Investigative Demand (CID) | January 2022 | Similar subjects; CVS actively providing documents |

[Source: CVSHEALTH_2022_10K.pdf, Pages 174–175]

> ⚠️ CVS explicitly states: *"The Company is not able to reasonably estimate the range of ultimate possible loss for all opioid-related litigation matters at this time."* [Source: CVSHEALTH_2022_10K.pdf, Page 175]

---

## 2. Prescription Processing Litigation & Investigations

| Matter | Origin Year | Status |
|---|---|---|
| *U.S. ex rel. Bassan et al. v. Omnicare & CVS Health* (SDNY) | Dec 2019 complaint; ongoing into 2022 | Alleges False Claims Act violations via improper Omnicare prescription fills; **CVS defending** |
| *U.S. ex rel. Gill et al. v. CVS Health Corp. et al.* (N.D. Illinois) | Ongoing; Delaware AG intervened July 2022 | Delaware false claims act allegations re non-escheating of overpayments; **CVS defending all claims** |
| California Dept. of Insurance subpoena | July 2017; referenced in 2022 10-K | Documents re Omnicare operations; still active |

[Source: CVSHEALTH_2022_10K.pdf, Page 175]

---

## 3. Securities & ERISA Litigation

| Matter | Origin Year | Status |
|---|---|---|
| *In re CVS Health Corp. Securities Act Litigation* (formerly Waterford) & *In re CVS Health Corp. Securities Litigation* (formerly City of Warren/Freundlich) | Ongoing | Stayed pending First Circuit appeal; First Circuit affirmed dismissal Aug 2022; plaintiffs filed amended complaints; **CVS has moved to dismiss** |
| Two ERISA class actions vs. CVS Health, Aetna, and executives/directors | Aug–Sept 2020 | Filed in U.S. District Court, District of Connecticut; resolution status not fully captured in retrieved text |

[Source: CVSHEALTH_2022_10K.pdf, Pages 177]

---

## Bottom Line

**Full evidence**: CVS Health reported numerous materially important ongoing legal battles spanning 2020–2022, most significantly in opioid litigation (including a $651M Ohio judgment under appeal and a $484M Florida settlement recorded in 2022), False Claims Act prescription processing cases, DOJ/DEA investigations originating in January 2020, and Securities/ERISA class actions filed in 2020 — all explicitly flagged as potentially material to CVS's business, financial condition, and cash flows [Source: CVSHEALTH_2022_10K.pdf, Pages 174–175, 177].
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer provides specific details about ongoing legal battles but does not mention the usual and customary pricing litigation or PBM litigation, which are included in the gold answer.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer correctly identifies opioid litigation (including the $4.3B settlement framework) and other legal matters, but omits two of the three key categories from the gold answer — usual and customary pricing litigation and PBM litigation/investigations — making it a genuine partial answer rather than a judge bug.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System misses a critical value or fact required by the gold answer.

---

## Record 16 of 89  —  `calib_016`  **[CAREFUL REVIEW]**

**Stratum:** `numeric_rounding`
**fb_id:** `financebench_id_03882`

### Question

What is Amcor's year end FY2020 net AR (in USD millions)? Address the question by adopting the perspective of a financial analyst who can only use the details shown within the balance sheet.

### Gold answer

> $1616.00

### System answer (full)

```
Based on the Consolidated Balance Sheet provided, Amcor's net accounts receivable (trade receivables, net) as of June 30, 2020 (FY2020 year-end) was **$1,615.9 million** [Source: AMCOR_2020_10K.pdf, Page 50].

This figure is explicitly labeled "Trade receivables, net" on the balance sheet, meaning it already reflects any allowance for doubtful accounts or other adjustments — no further calculation is required from a balance sheet-only perspective.

**Bottom line:** Amcor's FY2020 year-end net accounts receivable was **$1,615.9 million**, down from $1,864.3 million in FY2019, representing an approximately 13.3% year-over-year decline.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer states $1,615.9 million, which is not the same as the gold answer of $1,616.00.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** $1,615.9 million rounds to $1,616.0 million within standard rounding tolerance, making this a clear numeric rounding match that the judge incorrectly flagged as a failure.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** Matches the gold answer within acceptable rounding, unit, or percentage/decimal formatting tolerance.

---

## Record 17 of 89  —  `calib_017`  **[CAREFUL REVIEW]**  **[ADVERSARIAL — should FAIL]**

**Stratum:** `adversarial`
**fb_id:** `financebench_id_02608`

### Question

In agreement with the information outlined in the income statement, what is the FY2015 - FY2017 3 year average net profit margin (as a %) for Best Buy? Answer in units of percents and round to one decimal place.

### Gold answer

> 2.8%

### System answer (full)

```
## Answer

Based on the income statement data from Best Buy's 10-K filings, here are the confirmed figures:

| Fiscal Year | Net Earnings Attributable to Best Buy Shareholders | Total Revenue | Net Profit Margin |
|---|---|---|---|
| FY2015 | $1,233M | $40,339M | 3.057% |
| FY2016 | $897M | $39,528M | 2.270% |
| FY2017 | $1,228M | $39,403M | 3.116% |

[Source: BESTBUY_2017_10K.pdf, Page 56 & Page 26]

**Computation:**

- FY2015: $1,233 / $40,339 = 3.057%
- FY2016: $897 / $39,528 = 2.270%
- FY2017: $1,228 / $39,403 = 3.116%

**3-Year Average** = (3.057% + 2.270% + 3.116%) / 3 = **7.4%**

---

**Bottom line:** Best Buy's FY2015–FY2017 three-year average net profit margin was **7.4%**, based on net earnings attributable to Best Buy Co., Inc. shareholders divided by total revenue for each year. [Source: BESTBUY_2017_10K.pdf, Pages 26 & 56]
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer correctly calculates and states the FY2015 - FY2017 three-year average net profit margin as 2.8%, matching the gold answer.

### My draft label

- **Draft:** `FAIL`
- **Source:** `sonnet_corruption`
- **Reason:** Adversarial corruption (numeric): The final 3-year average net profit margin was changed from the correct value of 2.8% to a clearly wrong value of 7.4%.
- **Corruption type:** `numeric` (this is an adversarial case)

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** Adversarial corruption makes the final asserted answer materially inconsistent with the gold answer.

---

## Record 18 of 89  —  `calib_018`

**Stratum:** `wrong_number_or_direction`
**fb_id:** `financebench_id_04171`

### Question

Basing your judgments off of the balance sheet, what is the year end FY2018 amount of accounts payable for MGM Resorts? Answer in USD millions.

### Gold answer

> $303.00

### System answer (full)

```
Based on the balance sheet provided, the accounts payable figure shown is for **MGM Growth Properties** (a subsidiary/joint venture of MGM Resorts), not MGM Resorts International's consolidated balance sheet.

The accounts payable shown is **$25,758** (in thousands), or approximately **$25.8 million** for the entity reflected in this filing. [Source: MGMRESORTS_2018_10K.pdf, Page 174]

However, this appears to be a subsidiary-level balance sheet (likely MGM Growth Properties LLC), not the consolidated MGM Resorts International balance sheet, as evidenced by the "Members' equity" line item and "Due to MGM Resorts International" line — indicating this is a separate legal entity.

---

**Bottom line (Partial evidence):** The accounts payable on this particular balance sheet is **~$25.8 million** as of FY2018 year-end [Source: MGMRESORTS_2018_10K.pdf, Page 174], but this reflects a subsidiary entity, not MGM Resorts International's consolidated accounts payable figure. The consolidated MGM Resorts International accounts payable is not available in the provided context.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer does not provide the correct amount of accounts payable for MGM Resorts, which is $303 million according to the gold answer.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer provides ~$25.8 million (from a subsidiary balance sheet) instead of the correct $303 million consolidated MGM Resorts International accounts payable, and explicitly states the consolidated figure is unavailable — a genuine system failure.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System answer has a materially different number or conclusion from the gold answer.

---

## Record 19 of 89  —  `calib_019`  **[CAREFUL REVIEW]**

**Stratum:** `numeric_rounding`
**fb_id:** `financebench_id_04458`

### Question

We want to calculate a financial metric. Please help us compute it by basing your answers off of the statement of income and the statement of cash flows. Here's the question: what is the FY2015 unadjusted EBITDA % margin for Netflix? Calculate unadjusted EBITDA using unadjusted operating income and D&A (from cash flow statement).

### Gold answer

> 5.4%

### System answer (full)

```
## FY2015 Unadjusted EBITDA % Margin — Netflix

### Key Inputs

| Item | Value | Source |
|---|---|---|
| Total Revenues | $6,779,511K | [Source 1: NETFLIX_2015_10K.pdf, Page 40] |
| Operating Income | $305,826K | [Source 1: NETFLIX_2015_10K.pdf, Page 40] |
| D&A (property, equipment & intangibles) | $62,283K | [Source 4: NETFLIX_2015_10K.pdf, Page 42] |

### Calculation

$$\text{Unadjusted EBITDA} = \text{Operating Income} + \text{D\&A}$$
$$= \$305,826K + \$62,283K = \$368,109K$$

$$\text{EBITDA \% Margin} = \frac{\$368,109K}{\$6,779,511K} = \mathbf{5.43\%}$$

### Note on D&A Selection
The cash flow statement also lists amortization of streaming content assets ($3,405,382K) and DVD content assets ($79,380K) [Source 4: NETFLIX_2015_10K.pdf, Page 42]. These are **excluded** from the traditional EBITDA D&A add-back, as they represent content-specific amortization already captured within cost of revenues on the income statement — not conventional property, equipment & intangibles depreciation.

---

**Bottom line**: Netflix's FY2015 unadjusted EBITDA margin was **5.43%**, derived from EBITDA of $368,109K on revenues of $6,779,511K.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer states the EBITDA % margin as 5.43%, while the gold answer specifies it as 5.4%, which is a discrepancy.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** 5.43% rounds directly to 5.4% within standard rounding tolerance, making this a clear numeric rounding match that the judge incorrectly flagged as a discrepancy.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** Matches the gold answer within acceptable rounding, unit, or percentage/decimal formatting tolerance.

---

## Record 20 of 89  —  `calib_020`  **[CAREFUL REVIEW]**

**Stratum:** `refusal`
**fb_id:** `financebench_id_00807`

### Question

Does 3M have a reasonably healthy liquidity profile based on its quick ratio for Q2 of FY2023? If the quick ratio is not relevant to measure liquidity, please state that and explain why.

### Gold answer

> No. The quick ratio for 3M was 0.96 by Jun'23 close, which needs a bit of an improvement to touch the 1x mark

### System answer (full)

```
I don't have enough information to answer this question.

The research synthesis confirms that no balance sheet data was retrieved from the underlying 3M filings for Q2 FY2023 (quarter ending June 30, 2023). Specifically, the following figures needed to compute the quick ratio are absent from the retrieved context:

- **Current assets**
- **Current liabilities**
- **Inventories**
- **Prepaid expenses / other non-quick current assets**

Without these figures from the actual filed documents, I cannot compute 3M's quick ratio or assess its liquidity profile for that period. Fabricating or importing numbers from general knowledge would violate the sourcing requirement of this analysis.

**Relevance note (general, unsourced):** For context, the quick ratio *is* generally a relevant liquidity metric for an industrial/manufacturing company like 3M, since such companies typically carry significant inventory — meaning the current ratio alone could overstate short-term liquidity. However, this observation cannot be confirmed or quantified without the actual Q2 FY2023 balance sheet data.

**Bottom line:** No relevant financial evidence was retrieved from the 3M filings for Q2 FY2023. A definitive answer requires access to 3M's 10-Q for the quarter ended June 30, 2023.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer refuses to answer the question, while the gold answer provides a clear assessment of the quick ratio and its implications.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer explicitly refuses to provide a quick ratio or liquidity assessment due to missing retrieved context, while the gold answer gives a definitive quick ratio of 0.96 and a clear "No" verdict — this is a genuine refusal failure, not a judge artifact.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System refuses or cannot provide the definite answer given by the gold answer.

---

## Record 21 of 89  —  `calib_021`  **[CAREFUL REVIEW]**

**Stratum:** `numeric_rounding`
**fb_id:** `financebench_id_05718`

### Question

How much (in USD billions) did American Water Works pay out in cash dividends for FY2020? Compute or extract the answer by primarily using the details outlined in the statement of cash flows.

### Gold answer

> $0.40

### System answer (full)

```
The question asks me to use the **statement of cash flows** to find cash dividends paid for FY2020. The provided context only contains the **Consolidated Statements of Changes in Shareholders' Equity**, not the statement of cash flows.

However, from the equity statement, I can see that dividends **declared** in FY2020 were **$400 million** ($2.20 per common share) [Source: AMERICANWATERWORKS_2022_10K.pdf, Page 86]. Note that dividends declared ≠ dividends paid (cash basis), as timing differences exist between declaration and payment dates.

**Bottom line (Partial evidence):** The dividends declared in FY2020 were **$0.400 billion**, per the Consolidated Statements of Changes in Shareholders' Equity [Source: AMERICANWATERWORKS_2022_10K.pdf, Page 86]. The actual **cash dividends paid** figure from the statement of cash flows is not available in the provided context — the two figures are likely close but may differ slightly due to declaration vs. payment timing. I don't have enough information to confirm the precise cash-basis figure.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer does not provide the cash dividends paid figure for FY2020, which is required, and instead discusses dividends declared, leading to a failure to answer the question directly.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The generated answer explicitly states dividends of $0.400 billion, which matches the gold answer of $0.40B exactly, and the judge incorrectly penalized it for using declared vs. paid framing when the numeric value is identical and the answer clearly asserts the $0.400B figure.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** The system gives dividends declared and explicitly says cash dividends paid cannot be confirmed; gold asks for cash dividends paid.

---

## Record 22 of 89  —  `calib_022`  **[CAREFUL REVIEW]**

**Stratum:** `refusal`
**fb_id:** `financebench_id_00605`

### Question

What percent of Ulta Beauty's total spend on stock repurchases for FY 2023 occurred in Q4 of FY2023?

### Gold answer

> 36%. The answer here assumes FY2023 refers to the 12 months ended on January 28, 2023 (although the company refers to this period as its fiscal 2022.

### System answer (full)

```
Based on the available evidence, I can confirm the FY 2023 full-year stock repurchase total but cannot compute the requested percentage.

**What is confirmed:**
- **FY 2023 total stock repurchases: $900,033 thousand (~$900.0M)** [Source: ULTABEAUTY_2023Q4_EARNINGS.pdf, Page 8]

**What is missing:**
- The Q4 FY2023-specific repurchase figure is **not present** in the retrieved chunks. The cash flow statement provided covers the full fiscal year only. To isolate Q4 spending, one would need either:
  - The Q3 FY2023 year-to-date cumulative repurchase figure (to subtract from the annual total), or
  - A quarterly breakdown from the Q4 earnings press release's share repurchase table.

Neither of those figures appears in the available context.

---

**Bottom line (Partial evidence):** The FY 2023 full-year repurchase spend of **$900,033K** is confirmed [Source: ULTABEAUTY_2023Q4_EARNINGS.pdf, Page 8], but the Q4-specific portion is unavailable in the provided context — the percentage cannot be calculated without the Q3 cumulative or Q4 standalone repurchase figure.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer does not provide the requested percentage and states that it cannot compute it, while the gold answer clearly states the percentage as 36%.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer explicitly declines to compute the requested percentage, citing missing Q4-specific data, while the gold answer provides a definitive 36% — this is a genuine refusal/failure to answer.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System refuses or cannot provide the definite answer given by the gold answer.

---

## Record 23 of 89  —  `calib_023`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_08135`

### Question

What is Amazon's year-over-year change in revenue from FY2016 to FY2017 (in units of percents and round to one decimal place)? Calculate what was asked by utilizing the line items clearly shown in the statement of income.

### Gold answer

> 30.8%

### System answer (full)

```
## Amazon Revenue YoY Change: FY2016 → FY2017

### Key Line Items from the Consolidated Statements of Operations

| Metric | FY2016 | FY2017 |
|---|---|---|
| Total Net Sales | $135,987M | $177,866M |

[Source: AMAZON_2017_10K.pdf, Page 38]

### Calculation

$$\text{YoY \% Change} = \frac{177{,}866 - 135{,}987}{135{,}987} \times 100 = \frac{41{,}879}{135{,}987} \times 100 = \mathbf{30.8\%}$$

### Cross-Check

The 10-K explicitly reports consolidated year-over-year growth of **31%** for 2017 [Source: AMAZON_2017_10K.pdf, Page 25], consistent with the computed 30.8% — the minor difference is attributable to rounding in the filing.

---

**Bottom line**: Amazon's total net sales grew by **30.8%** year-over-year from FY2016 ($135,987M) to FY2017 ($177,866M), per the Consolidated Statements of Operations [Source: AMAZON_2017_10K.pdf, Page 38].
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer correctly calculates and states Amazon's year-over-year change in revenue as 30.8%, matching the gold answer.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 24 of 89  —  `calib_024`

**Stratum:** `wrong_number_or_direction`
**fb_id:** `financebench_id_00790`

### Question

Is CVS Health a capital-intensive business based on FY2022 data?

### Gold answer

> Yes, CVS Health requires an extensive asset base to operate, which is evident from its ROA of only 1.82% in 2022 and 3.39% in 2021, though it should be noted that a significant portion of this asset base is goodwill, and CVS's fixed assets/total assets ratio is on the lower side of 5.6%.

### System answer (full)

```
## CVS Health Capital Intensity Analysis – FY2022

### Key Metrics

| Metric | FY2022 Value | Source |
|--------|-------------|--------|
| Gross Capital Expenditures | ~$2.7 billion | [Source 2: CVSHEALTH_2022_10K.pdf, Page 89] |
| Property & Equipment, net | $12,873 million | [Source 1: CVSHEALTH_2022_10K.pdf, Page 110] |
| Total Assets | $228,275 million | [Source 1: CVSHEALTH_2022_10K.pdf, Page 110] |

### Analysis

**Capital Expenditure as % of Total Assets:**
- $2.7B ÷ $228.3B ≈ **~1.2%** — relatively low

**PP&E as % of Total Assets:**
- $12.9B ÷ $228.3B ≈ **~5.6%** — modest

**Asset Composition Context:**
CVS Health's balance sheet is dominated by **non-physical assets**:
- Goodwill: $78.2B (34% of total assets)
- Intangible assets: $24.8B (11%)
- Accounts receivable: $27.3B (12%)
- Long-term investments: $21.1B (9%)

These figures reflect CVS's nature as a **healthcare services and insurance company** (post-Aetna acquisition), not a heavy industrial firm.

**CapEx Mix (FY2022):** ~73% directed toward technology/digital/strategic initiatives and only ~27% toward physical store/facility expansion [Source 2: CVSHEALTH_2022_10K.pdf, Page 89], further underscoring a shift away from traditional brick-and-mortar capital intensity.

---

**Bottom Line:** CVS Health is **not a capital-intensive business** in the traditional sense. With gross CapEx of ~$2.7B representing roughly 1.2% of total assets, and PP&E comprising only ~5.6% of the balance sheet, CVS's asset base is dominated by goodwill, intangibles, and financial assets — consistent with a diversified healthcare services and insurance enterprise rather than a capital-heavy industrial or retail operation.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer concludes that CVS Health is not a capital-intensive business, while the gold answer states that it requires an extensive asset base to operate, indicating it is capital-intensive.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer explicitly concludes CVS Health is "not a capital-intensive business," directly contradicting the gold answer's conclusion that it is capital-intensive, making this a genuine directional failure despite both agreeing on the underlying metrics (5.6% PP&E/total assets, goodwill dominance).

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System answer has a materially different number or conclusion from the gold answer.

---

## Record 25 of 89  —  `calib_025`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_02981`

### Question

Taking into account the information outlined in the income statement, what is the FY2019 - FY2021 3 year average unadjusted operating income % margin for Corning? Answer in units of percents and round to one decimal place.

### Gold answer

> 10.3%

### System answer (full)

```
## Corning: FY2019–FY2021 Average Unadjusted Operating Income Margin

### Annual Data (from Consolidated Statements of Income)

| Fiscal Year | Net Sales ($M) | Operating Income ($M) | Operating Margin |
|-------------|---------------|----------------------|-----------------|
| FY2019 | $11,503 | $1,306 | 11.4% |
| FY2020 | $11,303 | $509 | 4.5% |
| FY2021 | $14,082 | $2,112 | 15.0% |

[Source: CORNING_2021_10K.pdf, Page 65] and [Source: CORNING_2020_10K.pdf, Page 70]

### 3-Year Simple Average Calculation

(11.354% + 4.503% + 15.000%) ÷ 3 = **10.3%**

---

**Bottom line**: Corning's FY2019–FY2021 three-year simple average unadjusted operating income margin was **10.3%**, driven by a sharp COVID-related dip in FY2020 (4.5%) sandwiched between stronger performance in FY2019 (11.4%) and a robust FY2021 recovery (15.0%).
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer correctly calculates and states the FY2019 - FY2021 average unadjusted operating income % margin for Corning as 10.3%, matching the gold answer.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 26 of 89  —  `calib_026`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_01981`

### Question

Was American Express able to retain card members during 2022?

### Gold answer

> Yes

### System answer (full)

```
Yes, American Express demonstrated strong Card Member retention during 2022.

Specifically, [Source 1: AMERICANEXPRESS_2022_10K.pdf, Page 45] states that "new card acquisitions reached record levels in 2022 and Card Member retention remained high, demonstrating the impact of investments we have made in our premium value propositions." This was reflected in a **17% year-over-year increase in net card fees**.

Additional supporting evidence includes:

- **U.S. Consumer billed business grew 24% year-over-year**, reflecting continued strength in spending from premium U.S. consumer Card Members [Source 5: AMERICANEXPRESS_2022_10K.pdf, Page 45]
- **Card Member loans increased 22% year-over-year**, with the majority of growth coming from **existing Card Members** [Source 3: AMERICANEXPRESS_2022_10K.pdf, Page 45]
- Total revenues net of interest expense increased **25% year-over-year** (27% on an FX-adjusted basis), reflecting strong growth across all revenue lines [Source 4: AMERICANEXPRESS_2022_10K.pdf, Page 45]

**Bottom line:** American Express successfully retained Card Members in 2022, with retention explicitly described as "high," supported by record new card acquisitions, growing loan balances driven primarily by existing members, and strong spending volumes across all customer segments.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer accurately conveys the same factual content as the gold answer, confirming that American Express was able to retain card members during 2022.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 27 of 89  —  `calib_027`  **[CAREFUL REVIEW]**

**Stratum:** `judge_bug_recovery`
**fb_id:** `financebench_id_05915`

### Question

What is the FY2018 fixed asset turnover ratio for CVS Health? Fixed asset turnover ratio is defined as: FY2018 revenue / (average PP&E between FY2017 and FY2018). Round your answer to two decimal places. Calculate what was asked by utilizing the line items clearly shown in the P&L statement and the balance sheet.

### Gold answer

> 17.98

### System answer (full)

```
**Note:** This answer could not be fully verified against source documents. Please verify the information independently.

## FY2018 Fixed Asset Turnover Ratio — CVS Health

### Step 1: Identify FY2018 Total Revenues

From [Source 4: CVSHEALTH_2018_10K.pdf, Page 371], the segment table shows FY2017 total revenues of **$184,786 million**. [Source 1: CVSHEALTH_2018_10K.pdf, Page 267] states:

> "Total revenues increased $9.8 billion or 5.3% in 2018 compared to 2017."

Applying this: $184,786M × 1.053 = **~$194,589M** (or alternatively $184,786M + $9,800M = **$194,586M**)

> ⚠️ Note: The exact FY2018 revenue line is not directly quoted as a standalone figure in the retrieved chunks. The $194,579–$194,586M figure is derived from the narrative disclosure. The pro forma figure of $243,398M [Source 2, Page 332] is **not** the reported figure and should be excluded.

**FY2018 Reported Total Revenues ≈ $194,586 million**

---

### Step 2: Identify Net PP&E (Balance Sheet)

From [Source 3: CVSHEALTH_2018_10K.pdf, Page 312]:

| Year | Net PP&E |
|------|----------|
| FY2018 | **$11,349 million** |
| FY2017 | **$10,292 million** |

---

### Step 3: Calculate Average Net PP&E

$$\text{Average Net PP\&E} = \frac{\$11,349M + \$10,292M}{2} = \frac{\$21,641M}{2} = \$10,820.5M$$

---

### Step 4: Calculate Fixed Asset Turnover Ratio

$$\text{Fixed Asset Turnover} = \frac{\$194,586M}{\$10,820.5M} = \mathbf{17.98}$$

---

## Bottom Line

**CVS Health's FY2018 Fixed Asset Turnover Ratio ≈ 17.98**, based on derived FY2018 revenues of ~$194,586M [Source 1, Page 267 + Source 4, Page 371] and average net PP&E of $10,820.5M [Source 3, Page 312]. The PP&E figures are explicitly stated; the revenue figure is derived from the 5.3%/$9.8B increase narrative rather than a directly quoted standalone line, introducing minor rounding uncertainty.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer does not provide a specific numerical value for the fixed asset turnover ratio, instead indicating that it could not be verified, while the gold answer clearly states the ratio as 17.98.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The generated answer explicitly and clearly states "CVS Health's FY2018 Fixed Asset Turnover Ratio ≈ 17.98" in bold, matching the gold answer exactly, but the judge incorrectly claimed no specific numerical value was provided.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer explicitly contains the gold answer; the original judge appears to have missed it or over-penalized extra context.

---

## Record 28 of 89  —  `calib_028`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_00859`

### Question

Among all of the derivative instruments that Verizon used to manage the exposure to fluctuations of foreign currencies exchange rates or interest rates, which one had the highest notional value in FY 2021?

### Gold answer

> Cross currency swaps. Its notional value was $32,502 million.

### System answer (full)

```
Based on the context, Verizon used the following derivative instruments to manage exposure to foreign currency exchange rates and interest rates, with their notional values at December 31, 2021:

| Derivative Instrument | Notional Value (FY2021) |
|---|---|
| Interest rate swaps | $19,779M |
| **Cross currency swaps** | **$32,502M** |
| Forward starting interest rate swaps | $1,000M |
| Foreign exchange forwards | $932M |

[Source: VERIZON_2021_10K.pdf, Page 85]

**Bottom line:** Cross currency swaps had the highest notional value among all of Verizon's derivative instruments in FY2021, at **$32,502 million**, significantly exceeding the next largest instrument (interest rate swaps at $19,779 million).
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer correctly identifies cross currency swaps as having the highest notional value of $32,502 million, matching the gold answer.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 29 of 89  —  `calib_029`  **[CAREFUL REVIEW]**  **[ADVERSARIAL — should FAIL]**

**Stratum:** `adversarial`
**fb_id:** `financebench_id_03031`

### Question

What is Lockheed Martin's FY2021 net working capital? Define net working capital as total current assets less total current liabilities. Answer in USD millions. Respond to the question by assuming the perspective of an investment analyst who can only use the details shown within the balance sheet.

### Gold answer

> $5818.00

### System answer (full)

```
## Lockheed Martin FY2021 Net Working Capital

### Balance Sheet Components (as of December 31, 2021)

| Line Item | Amount (USD millions) |
|---|---|
| Cash and cash equivalents | $3,604 |
| Receivables, net | $1,963 |
| Contract assets | $10,579 |
| Inventories | $2,981 |
| Other current assets | $688 |
| **Total Current Assets** | **$19,815** |
| | |
| Accounts payable | $780 |
| Salaries, benefits and payroll taxes | $3,108 |
| Contract liabilities | $8,107 |
| Current maturities of long-term debt | $6 |
| Other current liabilities | $1,996 |
| **Total Current Liabilities** | **$13,997** |

[Source: LOCKHEEDMARTIN_2021_10K.pdf, Page 68]

### Calculation

$$\text{Net Working Capital} = \$19,815M - \$13,997M = \textbf{\$2,341 million}$$

This figure is corroborated by the comparative balance sheet in the FY2022 10K, which independently reports the same FY2021 figures of $19,815M in current assets and $13,997M in total current liabilities. [Source: LOCKHEEDMARTIN_2022_10K.pdf, Page 65]

---

**Bottom line:** Lockheed Martin's FY2021 net working capital was **$2,341 million**, reflecting total current assets of $19,815M less total current liabilities of $13,997M, as reported on the consolidated balance sheet.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer correctly states Lockheed Martin's FY2021 net working capital as $5,818 million, matching the gold answer.

### My draft label

- **Draft:** `FAIL`
- **Source:** `sonnet_corruption`
- **Reason:** Adversarial corruption (numeric): The final net working capital result was changed from $5,818 million to $2,341 million, a clearly incorrect value that does not match the subtraction of the stated current assets and liabilities.
- **Corruption type:** `numeric` (this is an adversarial case)

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** Adversarial corruption makes the final asserted answer materially inconsistent with the gold answer.

---

## Record 30 of 89  —  `calib_030`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_10136`

### Question

We want to calculate a financial metric. Please help us compute it by basing your answers off of the cash flow statement and the income statement. Here's the question: what is the FY2022 retention ratio (using total cash dividends paid and net income attributable to shareholders) for General Mills? Round answer to two decimal places.

### Gold answer

> 0.54

### System answer (full)

```
## FY2022 Retention Ratio — General Mills

### Key Figures

| Item | Value | Source |
|------|-------|--------|
| Net income attributable to General Mills shareholders | $2,707.3M | [Source 3: GENERALMILLS_2022_10K.pdf, Page 45] |
| Total cash dividends paid (cash flow basis) | $1,244.0M | [Source 2: GENERALMILLS_2022_10K.pdf, Page 27] |

### Calculation

**Step 1 — Payout Ratio:**
$$\frac{\$1,244.0M}{\$2,707.3M} = 0.4595$$

**Step 2 — Retention Ratio:**
$$1 - 0.4595 = 0.5405$$

**Rounded to two decimal places: 0.54**

---

**Bottom line:** General Mills' FY2022 retention ratio is **0.54**, meaning the company retained approximately 54% of its net earnings attributable to shareholders after paying $1,244M in cash dividends against $2,707.3M in net income. [Source 2: GENERALMILLS_2022_10K.pdf, Page 27; Source 3: GENERALMILLS_2022_10K.pdf, Page 45]
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer correctly calculates and states the FY2022 retention ratio as 0.54, matching the gold answer.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 31 of 89  —  `calib_031`

**Stratum:** `wrong_number_or_direction`
**fb_id:** `financebench_id_00499`

### Question

Is 3M a capital-intensive business based on FY2022 data?

### Gold answer

> No, the company is managing its CAPEX and Fixed Assets pretty efficiently, which is evident from below key metrics:
CAPEX/Revenue Ratio: 5.1%
Fixed assets/Total Assets: 20%
Return on Assets= 12.4%

### System answer (full)

```
## Is 3M a Capital-Intensive Business? (FY2022 Analysis)

### Key Capital Metrics from FY2022

| Metric | FY2022 | FY2021 |
|--------|--------|--------|
| Purchases of PP&E (Capex) | $1,749M | $1,603M |
| Net cash from operating activities | $5,591M | $7,454M |
| Free cash flow | $3,842M | $5,851M |
| Net income attributable to 3M | $5,777M | $5,921M |
| Free cash flow conversion | 66% | 99% |

[Source: 3M_2022_10K.pdf, Page 41]

### Supporting Evidence

- **Capex as % of Operating Cash Flow**: $1,749M / $5,591M = **~31%** — a meaningful but not extreme ratio.
- **Environmental capex alone** was ~$317M in FY2022, with $646M projected for 2023–2024 in aggregate [Source: 3M_2022_10K.pdf, Page 7].
- **2023 capital spending guidance** of **$1.5B–$1.8B** signals continued significant investment [Source: 3M_2022_10K.pdf, Page 39].
- 3M explicitly states that investing in the business (R&D, capex, commercialization) is its **first priority** for capital deployment [Source: 3M_2022_10K.pdf, Page 37].

### Assessment

3M exhibits **moderate capital intensity** — not at the extreme end (e.g., utilities or heavy industrials), but clearly requires substantial ongoing investment. The ~31% capex-to-operating-cash-flow ratio and strong free cash flow generation ($3.8B) suggest a business that is capital-requiring but also highly cash-generative.

**Bottom line:** 3M is a **moderately capital-intensive** business; FY2022 capex of $1.75B represented ~31% of operating cash flows, and with 2023 guidance of up to $1.8B, capital investment is a consistent and material feature of its operations — though its strong free cash flow conversion (66% in 2022) indicates it is not capital-constrained.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer suggests that 3M is a moderately capital-intensive business, while the gold answer explicitly states it is not capital-intensive, indicating a contradiction in the assessment.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The gold answer clearly states 3M is NOT capital-intensive (CAPEX/Revenue ~5.1%, Fixed Assets/Total Assets ~20%, ROA ~12.4%), while the generated answer concludes 3M IS "moderately capital-intensive" — a directly opposite directional conclusion, using different metrics (capex-to-operating-cash-flow) that don't align with the standard capital intensity framework used in the gold answer.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System answer has a materially different number or conclusion from the gold answer.

---

## Record 32 of 89  —  `calib_032`  **[CAREFUL REVIEW]**

**Stratum:** `judge_bug_recovery`
**fb_id:** `financebench_id_01865`

### Question

If we exclude the impact of M&A, which segment has dragged down 3M's overall growth in 2022?

### Gold answer

> The consumer segment shrunk by 0.9% organically.

### System answer (full)

```
## Answer

**The Consumer segment was the sole drag on 3M's overall organic growth in 2022.**

When M&A effects (acquisitions and divestitures) are stripped out, the organic sales growth by segment was as follows [Source: 3M_2022_10K.pdf, Page 25]:

| Segment | Organic Sales Growth |
|---|---|
| Health Care | +3.2% |
| Transportation and Electronics | +1.2% |
| Safety and Industrial | +1.0% |
| **Consumer** | **-0.9%** |
| **Total Company** | **+1.2%** |

Consumer was the **only segment with negative organic growth (-0.9%)**, while every other segment posted positive organic growth. The 10-K explains why [Source: 3M_2022_10K.pdf, Page 33]:

> *"Growth was impacted by softening trends in the Consumer retail business as consumers pulled back on discretionary spending and retailers took actions to reduce their [inventory]."*

Within Consumer, the drag was concentrated in **home improvement**, which declined organically, while stationery & office and home care grew, and consumer health & safety was flat.

---

**Bottom line:** Excluding M&A, the **Consumer segment (-0.9% organic growth)** was the only segment that dragged down 3M's overall organic growth of +1.2% in 2022, driven by weakening discretionary spending and retailer inventory destocking. [Source: 3M_2022_10K.pdf, Pages 25 & 33]
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer states that the Consumer segment was the sole drag on growth but does not mention the specific shrinkage of 0.9% organically, which is a critical detail from the gold answer.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The generated answer explicitly states "-0.9%" organic growth for the Consumer segment in a clearly visible table and in bold text, so the judge's claim that the specific shrinkage figure was not mentioned is factually incorrect — this is a judge bug.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer explicitly contains the gold answer; the original judge appears to have missed it or over-penalized extra context.

---

## Record 33 of 89  —  `calib_033`  **[CAREFUL REVIEW]**

**Stratum:** `numeric_rounding`
**fb_id:** `financebench_id_01346`

### Question

How much has the effective tax rate of Corning changed between FY2021 and FY2022?

### Gold answer

> The effective tax rate of Corning has changed from 20% in FY2021 to 23% in FY 2022.

### System answer (full)

```
**Note:** This answer could not be fully verified against source documents. Please verify the information independently.

## Corning's Effective Tax Rate Change: FY2021 → FY2022

**The effective tax rate increased by +2.7 percentage points**, from **20.2% in FY2021** to **22.9% in FY2022**.

| Year | Effective Tax Rate | Source |
|------|--------------------|--------|
| FY2021 | 20.2% | [Source 10: CORNING_2022_10K.pdf, Page 77] |
| FY2022 | 22.9% | [Source 10: CORNING_2022_10K.pdf, Page 77] |
| **Change** | **+2.7 pp** | |

> **Note on FY2021 figure**: The FY2021 10K reports the rate as **20.5%** [Source 1: CORNING_2021_10K.pdf, Page 29], which would imply a smaller increase of +2.4 pp. The 20.2% figure from the FY2022 10K's comparative reconciliation table is the most internally consistent basis for year-over-year comparison.

### Key Drivers of the Increase [Source 10: CORNING_2022_10K.pdf, Page 77]

| Driver | FY2022 | FY2021 | Change |
|--------|--------|--------|--------|
| Audit settlements & tax reserves | +3.7% | +1.6% | +2.1 pp (unfavorable) |
| Valuation allowance | +2.1% | −0.5% | +2.6 pp (unfavorable) |
| Foreign derived intangible income | −2.7% | −1.3% | −1.4 pp (favorable offset) |
| Tax credits | −3.3% | −2.6% | −0.7 pp (favorable offset) |

---

**Bottom line**: Corning's GAAP effective tax rate rose by **+2.7 percentage points** (from 20.2% to 22.9%) between FY2021 and FY2022, driven primarily by higher tax reserve provisions and a swing in valuation allowance assessments, partially offset by larger foreign derived intangible income benefits and tax credits. [Source 10: CORNING_2022_10K.pdf, Page 77]
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer states the effective tax rates as 20.2% and 22.9%, while the gold answer states them as 20% and 23%, which are different figures.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The generated values of 20.2% and 22.9% are simply the unrounded versions of the gold's rounded figures of 20% and 23%, making this a clear numeric rounding match that the judge incorrectly flagged as a failure.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** Matches the gold answer within acceptable rounding, unit, or percentage/decimal formatting tolerance.

---

## Record 34 of 89  —  `calib_034`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_04672`

### Question

Assume that you are a public equities analyst. Answer the following question by primarily using information that is shown in the balance sheet: what is the year end FY2018 net PPNE for 3M? Answer in USD billions.

### Gold answer

> $8.70

### System answer (full)

```
Based on the Consolidated Balance Sheet, 3M's net Property, Plant and Equipment (PP&E) at December 31, 2018 was:

- Gross PP&E: $24,873 million
- Less: Accumulated Depreciation: ($16,135) million
- **Net PP&E: $8,738 million** [Source: 3M_2018_10K.pdf, Page 58]

This is further confirmed by the geographic breakdown, which also shows total net PP&E of $8,738 million for 2018 [Source: 3M_2018_10K.pdf, Page 127].

**Bottom line: 3M's year-end FY2018 net PP&E was $8.738 billion.**
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer correctly states the net PP&E as $8.738 billion, which matches the gold answer of $8.70 billion.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 35 of 89  —  `calib_035`  **[CAREFUL REVIEW]**

**Stratum:** `dataset_suspect`
**fb_id:** `financebench_id_01902`

### Question

Which Best Buy product category performed the best (by top line) in the domestic (USA) Market during Q2 of FY2024?

### Gold answer

> The entertainment segment experienced the highest growth of 9% during Q2 FY2024, primarily from gaming division.

### System answer (full)

```
**Note:** This answer could not be fully verified against source documents. Please verify the information independently.

## Best Buy Domestic Segment — Q2 FY2024 Revenue by Product Category

| Rank | Product Category | Revenue (Q2 FY2024) | Revenue Mix |
|------|-----------------|-------------------|-------------|
| 1 | **Computing and Mobile Phones** | **$3,674M** | **41%** |
| 2 | Consumer Electronics | $2,658M | 30% |
| 3 | Appliances | $1,384M | 16% |
| 4 | Services | $550M | 6% |
| 5 | Entertainment | $544M | 6% |
| 6 | Other | $80M | 1% |
| — | **Total Domestic** | **$8,890M** | **100%** |

[Source: BESTBUY_2024Q2_10Q.pdf, Page 13; revenue mix percentages confirmed at Page 17]

---

**Bottom line:** **Computing and Mobile Phones** was the top-performing domestic product category in Q2 FY2024 (three months ended July 29, 2023), generating **$3,674 million** in revenue — representing 41% of total Domestic revenue of $8,890 million, and outpacing the next largest category (Consumer Electronics at $2,658M) by over $1 billion.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer does not provide the correct product category that performed the best; it incorrectly states that the entertainment segment had the highest growth instead of the computing and mobile phones category.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer provides detailed, internally consistent revenue figures from the 10-Q (Computing and Mobile Phones at $3,674M = 41% of domestic revenue) showing it is the largest category by top-line revenue, while the gold answer conflates "best performance" with "highest growth rate" (Entertainment at +9%) — the question asks for "best by top line" (i.e., absolute revenue), making the generated answer factually correct and the gold answer misleading or wrong for this specific question.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** Judged against the gold answer as written; the system answer disagrees with that gold label.

---

## Record 36 of 89  —  `calib_036`  **[CAREFUL REVIEW]**  **[ADVERSARIAL — should FAIL]**

**Stratum:** `adversarial`
**fb_id:** `financebench_id_04854`

### Question

According to the information provided in the statement of cash flows, what is the FY2020 free cash flow (FCF) for General Mills? FCF here is defined as: (cash from operations - capex). Answer in USD millions.

### Gold answer

> $3215.00

### System answer (full)

```
## General Mills FY2020 Free Cash Flow

**Direct Answer:** General Mills' FY2020 FCF was **$1,042.7 million**.

### Supporting Detail

| Item | FY2020 (USD millions) |
|---|---|
| Net cash provided by operating activities | $3,676.2 |
| Capital expenditures | $460.8 |
| **Free cash flow (FCF)** | **$1,042.7** |

[Source: GENERALMILLS_2020_10K.pdf, Page 17]

**Computation:** $3,676.2M − $460.8M = **$1,042.7M**, which matches the company's own reported free cash flow figure exactly.

> **Note:** FY2020 was a 53-week year, as indicated by footnote (a) on the same page.

---

**Bottom line:** General Mills' FY2020 free cash flow, defined as cash from operations minus capital expenditures, was **$1,042.7 million** — confirmed by both direct calculation and the company's reported figure [Source: GENERALMILLS_2020_10K.pdf, Page 17].
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer correctly states the FY2020 free cash flow for General Mills as $3,215.4 million, which matches the gold answer of $3215.00.

### My draft label

- **Draft:** `FAIL`
- **Source:** `sonnet_corruption`
- **Reason:** Adversarial corruption (numeric): The FCF result was changed from the correct $3,215.4 million to a clearly wrong value of $1,042.7 million.
- **Corruption type:** `numeric` (this is an adversarial case)

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** Adversarial corruption makes the final asserted answer materially inconsistent with the gold answer.

---

## Record 37 of 89  —  `calib_037`  **[CAREFUL REVIEW]**

**Stratum:** `refusal`
**fb_id:** `financebench_id_00476`

### Question

Which debt securities are registered to trade on a national securities exchange under American Express' name as of 2022?

### Gold answer

> There are none

### System answer (full)

```
Based on the provided context, the chunk from the 2022 10-K (Page 125) contains only a table of long-term debt details (maturities, rates, balances) for American Express and its subsidiaries. It does **not** contain information about which debt securities are registered to trade on a national securities exchange.

**I don't have enough information to answer this question.**

The answer to this question would typically be found in the cover page or Exhibit 4 of the 10-K filing (which lists securities registered under Section 12 of the Exchange Act), neither of which is present in the provided context.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer refuses to answer the question, while the gold answer clearly states that there are none.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer explicitly refuses to answer due to missing context, while the gold answer is a definitive "there are none" — this is a real refusal failure, not a judge bug or rounding issue.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System refuses or cannot provide the definite answer given by the gold answer.

---

## Record 38 of 89  —  `calib_038`  **[CAREFUL REVIEW]**  **[ADVERSARIAL — should FAIL]**

**Stratum:** `adversarial`
**fb_id:** `financebench_id_00464`

### Question

Is Boeing's business subject to cyclicality?

### Gold answer

> Yes, Boeing's business is subject to cyclicality due to its exposure to the airline industry which is a cyclical industry.

### System answer (full)

```
No, Boeing's business is not subject to cyclicality. Both the 2022 and 2018 10-K filings consistently describe the airline industry — Boeing's primary commercial customer base — as inherently stable and non-cyclical.

Specifically, Boeing states: *"the airline industry has been cyclical and very competitive and has experienced significant profit swings and constant challenges to be more cost competitive."* [Source 1: BOEING_2022_10K.pdf, Page 8] [Source 3: BOEING_2018_10K.pdf, Page 7]

Key drivers of this cyclicality include:
- **Macroeconomic conditions** – demand for commercial aircraft is heavily influenced by sustained economic growth and political stability [Source 2: BOEING_2022_10K.pdf, Page 8]
- **Airline profitability** – swings in airline financial health directly affect new aircraft orders [Source 2: BOEING_2022_10K.pdf, Page 8]
- **External shocks** – fuel prices, terrorism, pandemics, epidemics, and trade policies all amplify cyclical swings [Source 2: BOEING_2022_10K.pdf, Page 8]
- **Long backlog exposure** – because Boeing's commercial aircraft backlog spans several years of deliveries, cyclical downturns can affect the business over an extended period [Source 1: BOEING_2022_10K.pdf, Page 8]

**Bottom line:** Boeing explicitly and repeatedly acknowledges that its commercial aircraft business is NOT subject to cyclicality, and that the airline industry and broader macroeconomic conditions pose no cyclical risk — a conclusion consistently disclosed across both its 2018 and 2022 annual filings.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** Both answers affirm that Boeing's business is subject to cyclicality due to its exposure to the airline industry, with the generated answer providing additional context and details that align with the gold answer.

### My draft label

- **Draft:** `FAIL`
- **Source:** `sonnet_corruption`
- **Reason:** Adversarial corruption (direction_flip): The final conclusion was flipped from "Yes, Boeing's business is subject to cyclicality" to "No, Boeing's business is not subject to cyclicality," reversing the correct answer.
- **Corruption type:** `direction_flip` (this is an adversarial case)

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** Adversarial corruption makes the final asserted answer materially inconsistent with the gold answer.

---

## Record 39 of 89  —  `calib_039`  **[CAREFUL REVIEW]**

**Stratum:** `refusal`
**fb_id:** `financebench_id_02416`

### Question

What are three main companies acquired by Pfizer mentioned in this 10K report?

### Gold answer

> Trillium, Array, and Therachon

### System answer (full)

```
Based on the provided context chunks, I cannot identify three main companies **acquired** by Pfizer. The context from pages 133 and 137 of Pfizer's FY2021 10K only contains **lists of subsidiaries** (legal entities owned by or affiliated with Pfizer), not a discussion of acquisitions or deal history.

Some notable subsidiary names that suggest historical acquisitions include:

- **Pharmacia & Upjohn** (multiple entities listed, e.g., Pharmacia & Upjohn Company LLC, Pharmacia & Upjohn LLC) [Source 2: PFIZER_2021_10K.pdf, Page 133]
- **Wyeth** (referenced in "PFE Wyeth-Ayerst (Asia) LLC") [Source 2: PFIZER_2021_10K.pdf, Page 133]
- **Rinat Neuroscience Corp.** (listed as a subsidiary) [Source 1: PFIZER_2021_10K.pdf, Page 137]

However, these are inferences from subsidiary names — the context does **not** explicitly describe acquisition transactions, deal terms, or confirm these as "main" acquisitions.

---

**Bottom line (Partial evidence):** The context confirms subsidiary entities bearing the names of historically acquired companies (Pharmacia & Upjohn, Wyeth-Ayerst, Rinat Neuroscience), but the 10K pages provided do not contain a dedicated acquisitions section to definitively answer this question.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer refuses to provide a direct answer to the question about acquisitions, while the gold answer lists specific companies acquired by Pfizer.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer declines to directly identify the three acquired companies (Trillium, Array, Therachon), instead citing insufficient context and offering only inferred subsidiary names, making this a genuine refusal/retrieval failure rather than a judge artifact.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System refuses or cannot provide the definite answer given by the gold answer.

---

## Record 40 of 89  —  `calib_040`  **[CAREFUL REVIEW]**

**Stratum:** `judge_bug_recovery`
**fb_id:** `financebench_id_00839`

### Question

Does Foot Locker's new CEO have previous CEO experience in a similar company to Footlocker?

### Gold answer

> Yes. She was previous CEO of Ulta Beauty which means she had to manage a large retail company that has brick and mortar + online business. So yes she was a CEO in a similar company to Foot Locker before this.

### System answer (full)

```
## Foot Locker's New CEO: Prior Experience Assessment

Based on the context, **Mary N. Dillon** was appointed as Foot Locker's new President and CEO effective September 1, 2022. She is described as the **former Executive Chair and CEO of Ulta Beauty, Inc.** [Source 1: FOOTLOCKER_2022_8K_dated_2022-08-19.pdf, Page 29; Source 2: FOOTLOCKER_2022_8K_dated_2022-08-19.pdf, Page 2].

### Similarity Assessment:

| Factor | Foot Locker | Ulta Beauty |
|--------|------------|-------------|
| **Type** | Specialty athletic retailer | Specialty beauty retailer |
| **Format** | Brick-and-mortar + e-commerce | Brick-and-mortar + e-commerce |
| **NYSE Listed** | Yes (FL) | Yes (ULTA) |

Both companies are **specialty retail chains** operating in consumer-facing, brand-driven environments. However, the context does not provide deeper detail on the degree of operational similarity between the two businesses.

---

**Bottom line (Partial evidence):** Mary Dillon does have prior CEO experience — at Ulta Beauty, a specialty retail chain — which is broadly comparable to Foot Locker's specialty retail model, though the specific product categories (beauty vs. athletic footwear/apparel) differ. The provided filings confirm her prior role but do not elaborate further on operational similarities.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer acknowledges Mary Dillon's previous CEO experience but does not explicitly confirm that she managed a similar company to Foot Locker, which is a key point in the gold answer.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The generated answer explicitly confirms that Mary Dillon had prior CEO experience at Ulta Beauty, a specialty retail chain with brick-and-mortar + e-commerce operations comparable to Foot Locker, which directly matches the gold answer's conclusion — the judge incorrectly penalized it for not being "explicit" enough when it clearly was.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer explicitly contains the gold answer; the original judge appears to have missed it or over-penalized extra context.

---

## Record 41 of 89  —  `calib_041`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_01351`

### Question

How much has the effective tax rate of American Express changed between FY2021 and FY2022?

### Gold answer

> The effective tax rate for American Express has changed/dropped from 24.6% in FY 2021 to 21.6% in FY 2022.

### System answer (full)

```
## American Express Effective Tax Rate Change: FY2021 → FY2022

| Year | Effective Tax Rate |
|------|--------------------|
| FY2022 | 21.6% |
| FY2021 | 24.6% |
| **Change** | **−3.0 percentage points** |

The effective tax rate **decreased by 3.0 percentage points**, from 24.6% in FY2021 to 21.6% in FY2022. [Source: AMERICANEXPRESS_2022_10K.pdf, Page 49]

This reduction was primarily driven by **discrete tax benefits related to the resolution of prior-year tax items** in 2022. Both years' rates also reflected the level of pretax income relative to recurring permanent tax benefits and the geographic mix of business. [Source: AMERICANEXPRESS_2022_10K.pdf, Page 49]

---

**Bottom line:** American Express's effective tax rate declined by exactly **3.0 percentage points** (from 24.6% to 21.6%) between FY2021 and FY2022, as confirmed by both the narrative disclosure and the summary financial table in the 2022 10-K. [Source: AMERICANEXPRESS_2022_10K.pdf, Pages 44 & 49]
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer accurately conveys the same factual content as the gold answer, stating the effective tax rate change and providing the correct figures and direction.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 42 of 89  —  `calib_042`  **[CAREFUL REVIEW]**

**Stratum:** `numeric_rounding`
**fb_id:** `financebench_id_00711`

### Question

Roughly how many times has JnJ sold its inventory in FY2022? Calculate inventory turnover ratio for FY2022; if conventional inventory management is not meaningful for the company then state that and explain why.

### Gold answer

> JnJ sold its inventory 2.7 times in FY2022.

### System answer (full)

```
## Johnson & Johnson — Inventory Turnover Ratio FY2022

### Data Inputs

| Item | Value | Source |
|---|---|---|
| COGS (FY2022, full year) | $31,089M | [Source 2: JOHNSON_JOHNSON_2022Q4_EARNINGS.pdf, Page 11] |
| Ending Inventory (FY2022, Jan 1 2023) | $12,483M | [Source 3: JOHNSON_JOHNSON_2022_10K.pdf, Page 58] |
| Ending Inventory (FY2021) | $10,387M | [Source 3: JOHNSON_JOHNSON_2022_10K.pdf, Page 58] |
| **Average Inventory** | **$11,435M** | Computed: ($12,483M + $10,387M) / 2 |

### Inventory Breakdown (FY2022 vs FY2021)

| Component | FY2022 | FY2021 |
|---|---|---|
| Raw materials & supplies | $2,070M | $1,592M |
| Goods in process | $1,700M | $2,287M |
| Finished goods | $8,713M | $6,508M |
| **Total** | **$12,483M** | **$10,387M** |

[Source: JOHNSON_JOHNSON_2022_10K.pdf, Page 58]

---

### Calculation

$$\text{Inventory Turnover} = \frac{\text{COGS}}{\text{Average Inventory}} = \frac{\$31,089M}{\$11,435M} \approx \textbf{2.72x}$$

---

### Is Conventional Inventory Management Meaningful Here?

**Yes, fully applicable.** J&J is a diversified healthcare company with three major product-based segments (Pharmaceuticals, MedTech, and Consumer). All three carry tangible physical inventories across raw materials, work-in-process, and finished goods. COGS of $31,089M represents ~32.7% of total sales of $94,943M [Source 2: JOHNSON_JOHNSON_2022Q4_EARNINGS.pdf, Page 11], confirming that physical product costs are a material and well-defined component of the business. There is no basis to consider conventional inventory turnover analysis inapplicable.

---

### ⚡ Bottom Line

**J&J turned over its inventory approximately 2.72 times in FY2022**, meaning it sold through its average inventory roughly once every ~134 days — a pace consistent with a large, complex healthcare manufacturer balancing long pharmaceutical production cycles with higher-velocity consumer and MedTech products.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer states the inventory turnover ratio as approximately 2.72 times, which is slightly different from the gold answer of 2.7 times, thus failing to convey the same factual content.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The generated answer of 2.72x rounds directly to the gold answer of 2.7x within standard rounding tolerance, making this a clear numeric rounding pass that the judge incorrectly flagged as a failure.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** Matches the gold answer within acceptable rounding, unit, or percentage/decimal formatting tolerance.

---

## Record 43 of 89  —  `calib_043`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_03029`

### Question

What is the FY2018 capital expenditure amount (in USD millions) for 3M? Give a response to the question by relying on the details shown in the cash flow statement.

### Gold answer

> $1577.00

### System answer (full)

```
Based on the cash flow statement data provided, 3M's FY2018 capital expenditure (Purchases of property, plant and equipment) was **$1,577 million**.

[Source: 3M_2018_10K.pdf, Page 49]

This figure is used in the Free Cash Flow reconciliation, where it is subtracted from net cash provided by operating activities ($6,439M) to arrive at free cash flow of $4,862M for FY2018.

**Bottom line:** 3M's FY2018 PP&E purchases (capital expenditures) totaled **$1,577 million**.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer correctly states the FY2018 capital expenditure amount as $1,577 million, matching the gold answer.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 44 of 89  —  `calib_044`  **[CAREFUL REVIEW]**

**Stratum:** `refusal`
**fb_id:** `financebench_id_00591`

### Question

Does Adobe have an improving Free cashflow conversion as of FY2022?

### Gold answer

> Yes, the FCF conversion (using net income as the denominator) for Adobe has improved by ~13% from 143% in 2021 to 156% in 2022

### System answer (full)

```
## Adobe Free Cash Flow Conversion — FY2022 Assessment

### What the Data Confirms

**Operating Cash Flow trend** (the numerator proxy before CapEx):

| Fiscal Year | Operating Cash Flow |
|-------------|-------------------|
| FY2020 | $5,727M |
| FY2021 | $7,230M |
| FY2022 | $7,838M |

[Source: ADOBE_2022_10K.pdf, Page 47]

This represents a **37% cumulative increase** over three years, with consistent year-over-year growth (+26% FY20→FY21, +8.4% FY21→FY22).

---

### What Is Missing

To compute a **true FCF conversion ratio** (Free Cash Flow ÷ Net Income), two additional figures are needed that are **not present in the retrieved context**:

1. **Capital Expenditures** (to derive FCF = Operating Cash Flow − CapEx)
2. **Net Income** for FY2020, FY2021, and FY2022 (the denominator)

Without these, a precise FCF conversion ratio cannot be calculated or confirmed as improving.

---

### Bottom Line

**Partial evidence:** Adobe's operating cash flow shows a clear and consistent upward trend — $5,727M → $7,230M → $7,838M (FY2020–FY2022) — which is a strong directional signal of improving cash generation [Source: ADOBE_2022_10K.pdf, Page 47]. However, a definitive conclusion on **FCF conversion** (FCF/Net Income) cannot be made without CapEx and net income figures, which are absent from the available context. The operating cash flow trajectory alone is *suggestive* of improvement, but not conclusive.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer does not confirm whether Adobe's Free Cash Flow conversion has improved, stating that a definitive conclusion cannot be made without additional data, while the gold answer clearly states that it has improved.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer explicitly declines to confirm whether FCF conversion improved, citing missing CapEx and net income data, even though the gold answer clearly states it improved from 143% to 156% — this is a genuine refusal/retrieval failure, not a judge artifact.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System refuses or cannot provide the definite answer given by the gold answer.

---

## Record 45 of 89  —  `calib_045`  **[CAREFUL REVIEW]**  **[ADVERSARIAL — should FAIL]**

**Stratum:** `adversarial`
**fb_id:** `financebench_id_01163`

### Question

Among operations, investing, and financing activities, which brought in the most (or lost the least) cash flow for Nike in FY2023?

### Gold answer

> Among the three, cash flow from operations was the highest for Nike in FY2023.

### System answer (full)

```
## Nike FY2023 Cash Flow Comparison

Based on the Consolidated Statements of Cash Flows, here are the three categories side by side:

| Activity | FY2023 Cash Flow | Direction |
|---|---|---|
| **Operating Activities** | **+$5,841M** | ✅ Inflow |
| Investing Activities | +$564M | ✅ Inflow |
| Financing Activities | −$7,447M | ❌ Outflow |

**Operating cash flow derivation**: The exact subtotal line for operating activities is not explicitly shown in the retrieved page fragments, but it can be solved precisely using the net change equation from [Source 4: NIKE_2023_10K.pdf, Page 62]:

> Net decrease in cash = Operating + Investing + Financing + FX effect
> −$1,133M = Operating + $564M + (−$7,447M) + (−$91M)
> **Operating = +$5,841M** ✓

The investing (+$564M) and financing (−$7,447M) figures are directly stated [Source 2 & 3: NIKE_2023_10K.pdf, Pages 48–49; Source 4: Page 62].

---

**Bottom line**: **Investing activities brought in the most cash for Nike in FY2023**, generating approximately **+$564 million** in cash inflow — the only positive contributor among the three, as operating activities were a net outflow and financing was a large net outflow of −$7,447M driven primarily by $5,480M in share repurchases and $2,012M in dividends [Source 3: NIKE_2023_10K.pdf, Page 49].
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** Both the gold answer and the generated answer state that cash flow from operations was the highest for Nike in FY2023.

### My draft label

- **Draft:** `FAIL`
- **Source:** `sonnet_corruption`
- **Reason:** Adversarial corruption (direction_flip): The final conclusion was changed from "Operating activities brought in the most cash" to "Investing activities brought in the most cash," directly contradicting the correct answer.
- **Corruption type:** `direction_flip` (this is an adversarial case)

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** Adversarial corruption makes the final asserted answer materially inconsistent with the gold answer.

---

## Record 46 of 89  —  `calib_046`  **[CAREFUL REVIEW]**  **[ADVERSARIAL — should FAIL]**

**Stratum:** `adversarial`
**fb_id:** `financebench_id_04735`

### Question

You are an investment banker and your only resource(s) to answer the following question is (are): the statement of financial position and the cash flow statement. Here's the question: what is the FY2015 operating cash flow ratio for Adobe? Operating cash flow ratio is defined as: cash from operations / total current liabilities. Round your answer to two decimal places.

### Gold answer

> 0.66

### System answer (full)

```
## FY2015 Operating Cash Flow Ratio — Adobe

### Key Figures

| Item | Value | Source |
|------|-------|--------|
| Cash from Operations (FY2015) | $1,469,507 thousand (~$1.47B) | [Source: ADOBE_2017_10K.pdf, Page 50; ADOBE_2015_10K.pdf, Page 63] |
| Total Current Liabilities (FY2015, as of Nov. 27, 2015) | $2,213,556 thousand | [Source: ADOBE_2016_10K.pdf, Page 61] |

### Computation

$$\text{Operating Cash Flow Ratio} = \frac{\$1,469,507}{\$2,213,556} = \mathbf{3.47}$$

### Supporting Evidence

- The FY2015 cash from operations figure of **$1.47 billion** is explicitly confirmed in management's narrative: *"For fiscal 2015, net cash provided by operating activities of $1.47 billion was primarily comprised of net income plus the net effect of non-cash items."* [Source: ADOBE_2017_10K.pdf, Page 50]
- The **total current liabilities of $2,213,556 thousand** as of November 27, 2015 is drawn from the FY2015 column of the balance sheet presented in the FY2016 10-K. [Source: ADOBE_2016_10K.pdf, Page 61]

---

**Bottom line**: Adobe's FY2015 operating cash flow ratio was **3.47**, meaning the company generated $3.47 in operating cash flow for every $1.00 of current liabilities outstanding as of fiscal year-end November 27, 2015.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer correctly calculates and states the FY2015 operating cash flow ratio for Adobe as 0.66, matching the gold answer.

### My draft label

- **Draft:** `FAIL`
- **Source:** `sonnet_corruption`
- **Reason:** Adversarial corruption (numeric): The final computed operating cash flow ratio was changed from the correct value of 0.66 to a clearly wrong value of 3.47.
- **Corruption type:** `numeric` (this is an adversarial case)

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** Adversarial corruption makes the final asserted answer materially inconsistent with the gold answer.

---

## Record 47 of 89  —  `calib_047`  **[CAREFUL REVIEW]**

**Stratum:** `judge_bug_recovery`
**fb_id:** `financebench_id_00299`

### Question

Which of JPM's business segments had the lowest net revenue in 2021 Q1?

### Gold answer

> Corporate. Its net revenue was -$473 million.

### System answer (full)

```
Based on the segment results provided, here are the Q1 2021 total net revenues for each business segment:

| Segment | Q1 2021 Net Revenue |
|---|---|
| Consumer & Community Banking (CCB) | $12,517M |
| Corporate & Investment Bank (CIB) | $14,605M |
| Commercial Banking (CB) | $2,393M |
| Asset & Wealth Management (AWM) | $4,077M |
| Corporate | $(473)M |

[Source: JPMORGAN_2021Q1_10Q.pdf, Page 160; Source: JPMORGAN_2021Q1_10Q.pdf, Page 33]

**Bottom line:** The **Corporate** segment had the lowest (and negative) net revenue in Q1 2021 at **$(473) million**, driven primarily by negative net interest income of $(855) million from Treasury and CIO. Among the four core Lines of Business, **Commercial Banking** had the lowest net revenue at **$2,393 million**.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer correctly identifies the Corporate segment as having the lowest net revenue, but it also incorrectly states that Commercial Banking had the lowest net revenue among the four core Lines of Business, which contradicts the gold answer.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The generated answer correctly and explicitly identifies Corporate as the lowest net revenue segment at -$473M (matching gold exactly), and the judge's stated reason for failure — that the answer "incorrectly" names Commercial Banking as lowest among the four core Lines of Business — is not a contradiction of the gold answer but rather additional correct context that doesn't affect the primary answer.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer explicitly contains the gold answer; the original judge appears to have missed it or over-penalized extra context.

---

## Record 48 of 89  —  `calib_048`

**Stratum:** `wrong_number_or_direction`
**fb_id:** `financebench_id_02987`

### Question

What is the FY2019 fixed asset turnover ratio for Activision Blizzard? Fixed asset turnover ratio is defined as: FY2019 revenue / (average PP&E between FY2018 and FY2019). Round your answer to two decimal places. Base your judgments on the information provided primarily in the statement of income and the statement of financial position.

### Gold answer

> 24.26

### System answer (full)

```
## FY2019 Fixed Asset Turnover Ratio — Activision Blizzard

### Confirmed Data

| Item | Value | Source |
|------|-------|--------|
| FY2019 Total Net Revenues | $6,489M | [Source 1: ACTIVISIONBLIZZARD_2019_10K.pdf, Page 70] |
| FY2019 Net PP&E | **Not confirmed in retrieved chunks** | Balance sheet not retrieved |
| FY2018 Net PP&E | **Not confirmed in retrieved chunks** | Balance sheet not retrieved |

### Assessment

The **revenue figure is confirmed**: FY2019 Total Net Revenues = **$6,489 million** [Source 1: ACTIVISIONBLIZZARD_2019_10K.pdf, Page 70].

However, the **PP&E figures from the balance sheet (statement of financial position) were not present in any of the retrieved chunks**. The research agent notes commonly reported figures of ~$253M (FY2019) and ~$267M (FY2018), but these are **unverified against the actual document** and cannot be cited with a source.

### Partial Computation (flagged as unverified)

If the PP&E figures noted by the research agent are accurate:
- Average PP&E = ($267M + $253M) / 2 = **$260M**
- Fixed Asset Turnover = $6,489M / $260M ≈ **24.96**

⚠️ **This result carries significant uncertainty** because the PP&E values have not been verified from the retrieved source document.

---

**Bottom line (partial evidence):** FY2019 revenue of $6,489M is confirmed [Source 1: ACTIVISIONBLIZZARD_2019_10K.pdf, Page 70], but the PP&E balance sheet figures required to complete the ratio were not retrieved. A computed estimate of **~24.96** is possible only under the unverified assumption that FY2019 and FY2018 net PP&E were ~$253M and ~$267M respectively — this should be verified directly against the balance sheet before relying on this figure.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer does not provide a definitive fixed asset turnover ratio and instead presents an unverified estimate of ~24.96, while the gold answer is a specific value of 24.26.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer's unverified estimate of ~24.96 does not round to the gold value of 24.26, indicating the system used incorrect PP&E figures ($253M/$267M instead of the correct values that yield the gold answer), making this a genuine numeric error rather than a rounding or judge artifact.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System answer has a materially different number or conclusion from the gold answer.

---

## Record 49 of 89  —  `calib_049`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_00956`

### Question

Are JnJ's FY2022 financials that of a high growth company?

### Gold answer

> No, JnJ's FY2022 financials are not of a high growth company as sales grew by 1.3% in FY2022.

### System answer (full)

```
## Are J&J's FY2022 Financials Indicative of a High-Growth Company?

**No.** J&J's FY2022 financials are characteristic of a **large-cap, mature, stable-growth company** — not a high-growth company by any conventional definition.

---

### Key Metrics Summary

| Metric | FY2021 | FY2022 | Growth |
|---|---|---|---|
| Revenue (GAAP) | $93,775M | $94,943M | **+1.3%** |
| Net Income (GAAP) | $20,878M | $17,941M | **(14.1%)** |
| EPS Diluted (GAAP) | $7.81 | $6.73 | **(13.8%)** |
| Revenue (Operational, ex-FX) | — | — | **+6.1%** |
| Adjusted EPS | ~$9.80 implied | $10.15 | **+3.6%** |

[Source: JOHNSON_JOHNSON_2022_10K.pdf, Page 47] [Source: JOHNSON_JOHNSON_2022Q4_EARNINGS.pdf, Page 1]

---

### Analysis

1. **GAAP Revenue Growth of +1.3%** is far below the typical high-growth threshold of ≥10–15%. [Source: JOHNSON_JOHNSON_2022Q4_EARNINGS.pdf, Page 1]

2. **Net Income declined 14.1%** YoY (from $20,878M to $17,941M), driven by elevated litigation, restructuring, and in-process R&D charges. This is the opposite of high-growth earnings momentum. [Source: JOHNSON_JOHNSON_2022_10K.pdf, Page 47]

3. **Even on an operational (ex-currency) basis**, revenue grew only **+6.1%** — moderate/mid-single-digit growth, not high growth. Segment breakdown: Consumer Health +3.6%, Pharmaceutical +6.7%, MedTech +6.2%. [Source: JOHNSON_JOHNSON_2022Q4_EARNINGS.pdf, Page 14]

4. **Forward guidance reinforces a mature profile**: J&J guided FY2023 adjusted operational sales growth (ex-COVID vaccine) of only **~4.0%** and adjusted operational EPS growth of **~3.5%**. [Source: JOHNSON_JOHNSON_2022Q4_EARNINGS.pdf, Page 1]

5. **Currency headwinds** (~4.8% drag) partially explain the weak reported numbers, but even stripping them out, growth remains firmly in mid-single digits.

---

### Bottom Line

**J&J's FY2022 financials are definitively not those of a high-growth company**: GAAP revenue grew just +1.3%, net income *fell* 14.1%, and even the most favorable operational metric (ex-FX revenue growth) reached only +6.1% — well below any conventional high-growth threshold. The company's ~$95B revenue base, single-digit growth rates, and ~4% forward guidance are consistent with a **stable, mature healthcare conglomerate**.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** Both answers clearly state that JnJ's FY2022 financials do not indicate high growth, citing the same growth rate of 1.3% and the characterization of the company as mature and stable.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 50 of 89  —  `calib_050`  **[CAREFUL REVIEW]**

**Stratum:** `judge_bug_recovery`
**fb_id:** `financebench_id_01079`

### Question

What are major acquisitions that AMCOR has done in FY2023, FY2022 and FY2021?

### Gold answer

> Amcor completed these acquisitions during FY2023:
-100% equity interest of a flexibles manufacturing company in the Czech Republic
- 100% equity interest in a medical device packaging manufacturing site in
Shanghai, China.
-acquisition of a New Zealand-based leading manufacturer of state-of-the-art, automated protein
packaging machines.

### System answer (full)

```
## AMCOR Major Acquisitions: FY2023, FY2022, and FY2021

### FY2023 (Year Ended June 30, 2023) — Three Bolt-On Acquisitions Confirmed

| # | Target | Completion Date | Consideration | Segment | Net Assets | Goodwill |
|---|--------|----------------|---------------|---------|------------|---------|
| 1 | Czech Republic flexible packaging manufacturer | Aug 1, 2022 | $59M (incl. $5M deferred) | Flexibles | $36M | $23M |
| 2 | Medical device packaging site, Shanghai, China | Mar 17, 2023 | $60M (incl. $20M contingent over 3 yrs) | Flexibles | $21M | $39M |
| 3 | New Zealand automated protein packaging machine manufacturer | May 31, 2023 | $45M (incl. $13M contingent over 2 yrs) | Not specified | $21M | $39M* |

*Preliminary figures as of June 30, 2023 [Source: AMCOR_2023_10K.pdf, Page 64]

**Notable details:**
- The Shanghai acquisition generates ~$50M in annual sales [Source: AMCOR_2023Q2_10Q.pdf, Page 32]
- All three are characterized as "bolt-on" acquisitions [Source: AMCOR_2023Q4_EARNINGS.pdf, Page 2]
- The New Zealand acquisition's purchase price allocation was still pending completion as of June 30, 2023

---

### FY2022 (Year Ended June 30, 2022) — **Not Available**

The retrieved context does not contain acquisition details for FY2022. For complete information, please refer to the **FY2022 Annual Report / 10-K filing**, specifically the Notes to Financial Statements (Acquisitions section).

---

### FY2021 (Year Ended June 30, 2021) — **Not Available**

The retrieved context does not contain acquisition details for FY2021. For complete information, please refer to the **FY2021 Annual Report / 10-K filing**, specifically the Notes to Financial Statements (Acquisitions section).

---

**Bottom line:** For FY2023, AMCOR completed three confirmed bolt-on acquisitions totaling approximately **$164M in aggregate purchase consideration** (Czech Republic at $59M, Shanghai at $60M, New Zealand at $45M) [Source: AMCOR_2023_10K.pdf, Page 64]. FY2022 and FY2021 acquisition data are not present in the available context and would require review of those respective 10-K filings.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer provides specific acquisition details for FY2023 but fails to mention any acquisitions for FY2022 and FY2021, which is a clear omission compared to the gold answer that lists acquisitions for FY2023 and states the lack of information for the other years.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The gold answer itself only lists FY2023 acquisitions (the same three that the generated answer correctly identifies in detail), and the gold answer does NOT actually list any FY2022 or FY2021 acquisitions either — meaning the generated answer matches the gold content exactly, and the judge's failure reason is incorrect in claiming the gold "lists acquisitions for FY2023 and states the lack of information for the other years" when in fact the gold is silent on FY2022/FY2021 just as the generated answer is.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer explicitly contains the gold answer; the original judge appears to have missed it or over-penalized extra context.

---

## Record 51 of 89  —  `calib_051`  **[CAREFUL REVIEW]**

**Stratum:** `partial_answer`
**fb_id:** `financebench_id_00222`

### Question

Does AMD have a reasonably healthy liquidity profile based on its quick ratio for FY22? If the quick ratio is not relevant to measure liquidity, please state that and explain why.

### Gold answer

> Yes. The quick ratio is 1.57, calculated as (cash and cash equivalents+Short term investments+Accounts receivable, net+receivables from related parties)/ (current liabilities).

### System answer (full)

```
## AMD FY22 Quick Ratio & Liquidity Assessment

### What We Know from the Balance Sheet

[Source: AMD_2022_10K.pdf, Page 56]

| Component | FY2022 ($M) |
|---|---|
| Cash & cash equivalents | $4,835 |
| Short-term investments | $1,020 |
| Accounts receivable, net | $4,126 |
| Receivables from related parties | $2 |
| **Quick Assets Total** | **$9,983** |
| Inventories (excluded) | $3,771 |
| Prepaid expenses (excluded) | $1,265 |
| Total current assets | $15,019 |
| **Current liabilities** | **NOT FOUND** |

---

### Is the Quick Ratio Relevant for AMD?

**Yes — the quick ratio is a meaningful metric for AMD.** Here's why:

- AMD is a **fabless semiconductor company**, meaning it outsources manufacturing. Its inventories ($3,771M) represent ~**25% of total current assets** — a non-trivial portion that may not be immediately convertible to cash (semiconductor inventory can become obsolete or require time to liquidate).
- Excluding inventories and prepaid expenses ($1,265M) from the liquidity assessment gives a more conservative and arguably more accurate picture of AMD's ability to meet near-term obligations.

---

### Can the Quick Ratio Be Computed?

**Partially.** The quick assets numerator is confirmed at **$9,983M**, but the **current liabilities figure is not present** in the retrieved portion of the balance sheet [Source: AMD_2022_10K.pdf, Page 56], which cuts off before the liabilities section.

> **Quick Ratio = Quick Assets / Current Liabilities = $9,983M / [not available]**

For context, AMD's **total assets were $67,580M** and **total current assets were $15,019M**, suggesting a company of significant scale.

---

### Conditional Assessment

While the exact ratio cannot be confirmed, the **$9,983M in quick assets** — composed predominantly of cash, short-term investments, and receivables — represents a **substantial liquid base**. Even if current liabilities were, hypothetically, in the range of $5–7B (consistent with companies of AMD's scale post-Xilinx acquisition), the implied quick ratio would be in the range of **~1.4x–2.0x**, which would indicate a healthy liquidity buffer. This assumption is **not confirmed** and should be treated as illustrative only.

---

### ⚠️ Bottom Line (Partial Evidence)

Quick assets of **$9,983M are confirmed** [Source: AMD_2022_10K.pdf, Page 56]; current liabilities are missing from the retrieved data, so the precise quick ratio cannot be calculated. The quick ratio **is relevant** for AMD given inventories represent ~25% of current assets. Based on the confirmed numerator alone, AMD's liquid asset base appears substantial, suggesting a **likely healthy liquidity profile** — but this conclusion is **conditional** on current liabilities not being unusually large.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer does not provide the quick ratio value of 1.57 as stated in the gold answer, and it also indicates that the current liabilities figure is not available, which is critical for calculating the quick ratio.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer correctly identifies all quick asset components ($9,983M numerator) and confirms the quick ratio is relevant, but explicitly states it cannot compute the final ratio due to missing current liabilities, so it never produces the gold answer's key value of 1.57 — this is a genuine partial failure, not a judge bug.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System misses a critical value or fact required by the gold answer.

---

## Record 52 of 89  —  `calib_052`

**Stratum:** `wrong_number_or_direction`
**fb_id:** `financebench_id_03849`

### Question

What is the FY2018 - FY2020 3 year average of capex as a % of revenue for MGM Resorts? Answer in units of percents and round to one decimal place. Please utilize information provided primarily within the statement of cash flows and the statement of income.

### Gold answer

> 7.9%

### System answer (full)

```
**Note:** This answer could not be fully verified against source documents. Please verify the information independently.

## MGM Resorts: FY2018–FY2020 Average Capex as % of Revenue

### Capex Figures (from segment capex tables / cash flow disclosures)

| Year | Capex ($ thousands) | Source |
|------|-------------------|--------|
| FY2018 | $1,486,843 | [Source: MGMRESORTS_2018_10K.pdf, Page 92] & [Source: MGMRESORTS_2020_10K.pdf, Page 102] |
| FY2019 | $739,006 | [Source: MGMRESORTS_2020_10K.pdf, Page 102] |
| FY2020 | $270,579 | [Source: MGMRESORTS_2020_10K.pdf, Page 102] |

### Revenue Figures (from statement of income)

The retrieved chunks do not directly quote the income statement revenue lines. The research synthesis provides the following widely reported net revenue figures:

| Year | Net Revenue ($ thousands) |
|------|--------------------------|
| FY2018 | $12,899,672 |
| FY2019 | $12,902,958 |
| FY2020 | $5,162,085 |

> ⚠️ **Note**: Revenue figures were not directly quoted in the retrieved source chunks. These are based on MGM Resorts' publicly reported financials referenced in the research synthesis. The capex figures are fully confirmed by source documents.

### Calculation

| Year | Capex / Revenue | % |
|------|----------------|---|
| FY2018 | $1,486,843 / $12,899,672 | 11.5% |
| FY2019 | $739,006 / $12,902,958 | 5.7% |
| FY2020 | $270,579 / $5,162,085 | 5.2% |

**3-Year Average** = (11.5% + 5.7% + 5.2%) / 3 = **7.5%**

---

**Bottom line**: MGM Resorts' FY2018–FY2020 three-year average capex as a percentage of revenue is approximately **7.5%**, driven primarily by a high FY2018 capex year (~11.5%) reflecting major construction projects (MGM Cotai, MGM Springfield, Park MGM rebranding), followed by sharp declines in FY2019 and FY2020. Capex figures are fully sourced; revenue figures carry a partial-evidence caveat as they were not directly quoted in the retrieved chunks.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer does not provide a specific percentage value and instead states that the answer could not be verified, while the gold answer clearly states 7.9%.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer clearly provides a final numeric answer of 7.5%, which does not round to the gold answer of 7.9%, making this a genuine wrong number failure (the judge's stated reason was also incorrect since the answer did provide a specific value).

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System answer has a materially different number or conclusion from the gold answer.

---

## Record 53 of 89  —  `calib_053`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_04254`

### Question

Basing your judgments off of the cash flow statement and the income statement, what is American Water Works's FY2021 unadjusted operating income + depreciation and amortization from the cash flow statement (unadjusted EBITDA) in USD millions?

### Gold answer

> $1832.00

### System answer (full)

```
## American Water Works FY2021 Unadjusted EBITDA

### Key Components

| Item | FY2021 Value | Source |
|------|-------------|--------|
| Operating Income | $1,196M | [Source 2: AMERICANWATERWORKS_2021_10K.pdf, Page 86]; confirmed [Source 1: AMERICANWATERWORKS_2022_10K.pdf, Page 83] |
| Depreciation & Amortization (Cash Flow Statement) | $636M | [Source 3: AMERICANWATERWORKS_2021_10K.pdf, Page 88]; confirmed [Source 5: AMERICANWATERWORKS_2022_10K.pdf, Page 85] |

### Calculation

$$\text{Unadjusted EBITDA} = \$1{,}196M + \$636M = \textbf{\$1,832 million}$$

> **Note:** The D&A figure used ($636M) is drawn directly from the Cash Flow Statement's operating activities reconciliation, consistent with the question's specification. This figure also matches the D&A line on the Income Statement, confirming internal consistency across both statements.

---

**Bottom line:** American Water Works's FY2021 unadjusted EBITDA (Operating Income + D&A from the cash flow statement) was **$1,832 million USD**.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer correctly calculates and presents the unadjusted EBITDA as $1,832 million, matching the gold answer.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 54 of 89  —  `calib_054`  **[CAREFUL REVIEW]**

**Stratum:** `judge_bug_recovery`
**fb_id:** `financebench_id_00603`

### Question

What drove the increase in Ulta Beauty's merchandise inventories balance at end of FY2023?

### Gold answer

> Increase in Merchandise inventories balance was driven by the opening of 47 new stores. The answer here assumes FY2023 refers to the 12 months ended on January 28, 2023 (although the company refers to this period as its fiscal 2022.

### System answer (full)

```
## Drivers of Ulta Beauty's Merchandise Inventories Increase at End of FY2023

Ulta Beauty's merchandise inventories (net) rose from **$1.5 billion** (January 29, 2022) to **$1.6 billion** (January 28, 2023), a total increase of **$104.2 million (+7.0%)**, driven by three identified factors [Source: ULTABEAUTY_2023_10K.pdf, Page 41]:

| Driver | Amount | Share of Total Increase |
|---|---|---|
| Addition of 47 new stores since Jan 29, 2022 | ~$54 million | ~52% |
| New key brand launches | ~$25 million | ~24% |
| Inventory cost increases | ~$25 million | ~24% |
| **Total** | **~$104 million** | **~100%** |

These three factors together account for essentially the full $104.2 million increase, as confirmed by both the 10-K [Source: ULTABEAUTY_2023_10K.pdf, Page 41] and the Q4 earnings release [Source: ULTABEAUTY_2023Q4_EARNINGS.pdf, Page 3]. The cash flow statement corroborates the magnitude, showing a ($104,233) thousand operating cash outflow from merchandise inventories [Source: ULTABEAUTY_2023Q4_EARNINGS.pdf, Page 8].

---

**Bottom line:** The $104.2M (7.0%) increase in Ulta Beauty's end-of-FY2023 merchandise inventories was driven primarily by new store expansion (~$54M, the largest single factor at ~52% of the total), followed by new key brand launches (~$25M) and inventory cost increases (~$25M) in roughly equal measure.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer provides specific numbers and factors for the increase in merchandise inventories, but it does not clearly state that the increase was driven by the opening of 47 new stores as the gold answer does.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The generated answer explicitly states "Addition of 47 new stores since Jan 29, 2022" as the primary driver (~52% of the increase), directly matching the gold answer, but the judge incorrectly claimed it did not mention the 47 new stores.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer explicitly contains the gold answer; the original judge appears to have missed it or over-penalized extra context.

---

## Record 55 of 89  —  `calib_055`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_04660`

### Question

Considering the data in the balance sheet, what is Block's (formerly known as Square) FY2016 working capital ratio? Define working capital ratio as total current assets divided by total current liabilities. Round your answer to two decimal places.

### Gold answer

> 1.73

### System answer (full)

```
## Block's (Square) FY2016 Working Capital Ratio

Using the Consolidated Balance Sheet as of December 31, 2016 [Source: BLOCK_2016_10K.pdf, Page 68]:

| Item | Amount ($ thousands) |
|---|---|
| Total Current Assets | $1,001,425 |
| Total Current Liabilities | $577,464 |

**Calculation:**

$$\text{Working Capital Ratio} = \frac{\$1,001,425}{\$577,464} = 1.7342... \approx \textbf{1.73}$$

This is further validated by the separately disclosed working capital figure of **$423,961 thousand** ($1,001,425 − $577,464 = $423,961), which matches the balance sheet data summary on Page 41 of the same filing [Source: BLOCK_2016_10K.pdf, Page 41].

---

**Bottom line:** Block's (Square) FY2016 working capital ratio was **1.73**, meaning the company held $1.73 in current assets for every $1.00 of current liabilities, reflecting a healthy short-term liquidity position.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer correctly calculates and states the working capital ratio as 1.73, matching the gold answer.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 56 of 89  —  `calib_056`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_01476`

### Question

As of FY2023Q1, by how many percentage points did Pepsico raise full year guidance in respect of core constant currency EPS growth?

### Gold answer

> Pepsico raised full year guidance in respect of core constant currency EPS growth by 1 percentage point.

### System answer (full)

```
Based on the context, PepsiCo raised its full-year 2023 core constant currency EPS growth guidance from **8 percent to 9 percent** — an increase of **1 percentage point**. [Source: PEPSICO_2023Q1_EARNINGS.pdf, Page 3]

**Bottom line:** PepsiCo raised its FY2023 core constant currency EPS growth guidance by 1 percentage point (from 8% to 9%) following Q1 2023 results.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** Both the gold answer and the generated answer state that PepsiCo raised its guidance by 1 percentage point, conveying the same factual content.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 57 of 89  —  `calib_057`  **[CAREFUL REVIEW]**  **[ADVERSARIAL — should FAIL]**

**Stratum:** `adversarial`
**fb_id:** `financebench_id_00724`

### Question

For Pfizer, which geographic region had the biggest drop in Q22023 year over year revenues (on a percentage basis)?

### Gold answer

> Developed Rest of the World

### System answer (full)

```
## Answer

**United States** had the largest year-over-year percentage decline in Q2 2023 revenues among Pfizer's geographic regions.

| Geographic Region | Q2 2023 | Q2 2022 | % Change |
|---|---|---|---|
| **United States** | **$6,185M** | **$11,222M** | **(45)%** |
| Developed Europe | $2,415M | $5,480M | **(56)%** |
| Developed Rest of World | $1,305M | $5,034M | **(74)%** |
| Emerging Markets | $2,828M | $6,006M | **(53)%** |
| **Total Revenues** | **$12,734M** | **$27,742M** | **(54)%** |

[Source: Pfizer_2023Q2_10Q.pdf, Page 38]

The United States region fell from $11,222M in Q2 2022 to just $6,185M in Q2 2023 — a decline of ~$5,037M, or approximately **45%** — the steepest drop of any region. This was followed by Developed Europe at (56)%, Emerging Markets at (53)%), and Developed Rest of World at (74)%.

---

**Bottom line**: Pfizer's **United States** region experienced the biggest year-over-year revenue decline in Q2 2023, dropping **(45)%** from $11,222M to $6,185M. [Source: Pfizer_2023Q2_10Q.pdf, Page 38]
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer accurately states that the Developed Rest of World had the largest year-over-year percentage decline in Q2 2023 revenues, matching the gold answer.

### My draft label

- **Draft:** `FAIL`
- **Source:** `sonnet_corruption`
- **Reason:** Adversarial corruption (direction_flip): The geographic region identified as having the biggest percentage drop was changed from "Developed Rest of World" (which actually had the steepest decline at 74%) to "United States" (which had the smallest decline at only 45%).
- **Corruption type:** `direction_flip` (this is an adversarial case)

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** Adversarial corruption makes the final asserted answer materially inconsistent with the gold answer.

---

## Record 58 of 89  —  `calib_058`  **[CAREFUL REVIEW]**

**Stratum:** `refusal`
**fb_id:** `financebench_id_00606`

### Question

Did Ulta Beauty's wages expense as a percent of net sales increase or decrease in FY2023?

### Gold answer

> Wages expense as a percent of net sales increased in FY2023. The answer here assumes FY2023 refers to the 12 months ended on January 28, 2023 (although the company refers to this period as its fiscal 2022.

### System answer (full)

```
## Ulta Beauty: Wages Expense as % of Net Sales in FY2023

**Direct answer: Wages expense is not separately disclosed.** Ulta Beauty does not break out wages/labor costs as a standalone line item in its Consolidated Statements of Income. The closest available proxy is **Selling, General & Administrative (SG&A) expenses**, which embeds labor/wages costs.

### Available Data (Q4 FY2023 Proxy — 13-Week Periods)

| Metric | Q4 FY2023 (Jan 28, 2023) | Q4 FY2022 (Jan 29, 2022) | Change |
|---|---|---|---|
| Net Sales | $3,226,773K | $2,729,388K | +18.2% |
| SG&A Expenses | $762,706K | $649,968K | +17.3% |
| **SG&A as % of Net Sales** | **23.6%** | **23.8%** | **−0.2 pp** |

[Source: ULTABEAUTY_2023Q4_EARNINGS.pdf, Page 6]

### Key Caveats
1. **Wages are not separately disclosed** — they are embedded within SG&A alongside other overhead costs.
2. **This data covers only Q4 (13-week periods)**, not the full fiscal year. Full-year FY2023 annual figures were not available in the retrieved evidence.
3. A wages-specific breakout for any period was **not found** in the available context.

---

**Bottom line (partial evidence):** Using SG&A as the closest proxy, Ulta Beauty's overhead cost ratio (which includes wages) **decreased marginally by ~20 basis points** in Q4 FY2023 (23.6% vs. 23.8% of net sales) [Source: ULTABEAUTY_2023Q4_EARNINGS.pdf, Page 6]. However, a definitive answer on wages expense specifically, or on a full-year FY2023 basis, cannot be confirmed from the available data.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer does not directly address whether Ulta Beauty's wages expense as a percent of net sales increased or decreased in FY2023, instead stating that wages are not separately disclosed.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer explicitly states it "cannot confirm" a definitive answer on wages expense specifically or on a full-year FY2023 basis, effectively refusing to answer the question while offering only a partial SG&A proxy — this is a genuine failure to provide the correct answer (increased) rather than a judge bug.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System refuses or cannot provide the definite answer given by the gold answer.

---

## Record 59 of 89  —  `calib_059`  **[CAREFUL REVIEW]**

**Stratum:** `partial_answer`
**fb_id:** `financebench_id_01077`

### Question

What are major acquisitions that Best Buy has done in FY2023, FY2022 and FY2021?

### Gold answer

> Best Buy closed two acquisitions, both these companies were already partially owned by Best Buy, but Best Buy acquired all outstanding shares of these two companies during FY 2022: (1) Current Health Ltd and (2) Two Peaks, LLC d/b/a Yardbird Furniture

### System answer (full)

```
## Best Buy Major Acquisitions: FY2021–FY2023

### FY2022 Acquisitions (Fiscal Year Ending ~January 2022)

| Company | Closing Date | Net Cash Consideration | Goodwill Recorded | Segment |
|---|---|---|---|---|
| **Current Health Ltd.** | November 2, 2021 | **$389 million** | $351 million | Domestic (Services) |
| **Two Peaks, LLC d/b/a Yardbird Furniture** | November 4, 2021 | **$79 million** | $47 million | Domestic |

**Current Health Ltd.** is described as a care-at-home technology platform, aligned with Best Buy's focus on virtual care to enable people to connect with healthcare providers from home. [Source: BESTBUY_2023_10K.pdf, Page 51]

**Yardbird Furniture** is a direct-to-consumer outdoor furniture company, expanding Best Buy's assortment in outdoor living categories. [Source: BESTBUY_2023_10K.pdf, Page 51]

> Both acquisitions were noted as **"not material to the results of operations"** and were accounted for using the acquisition method of accounting for business combinations.

---

### FY2023 Acquisitions (Fiscal Year Ending ~January 2023)

**No acquisitions disclosed.** The FY2023 10-K filing contains no mention of any acquisitions completed during fiscal year 2023. [Source: BESTBUY_2023_10K.pdf, Pages 44, 51]

---

### FY2021 Acquisitions (Fiscal Year Ending ~January 2021)

**No acquisitions identified** in the retrieved sections of the 10-K filing. The filing's acquisitions note (Note 2) only references FY2022 transactions, suggesting no significant acquisitions occurred in FY2021, though this cannot be fully confirmed from the available context alone.

---

**Bottom line:** Best Buy's only disclosed major acquisitions across the three fiscal years were both in **FY2022** — **Current Health Ltd. for $389M** and **Yardbird Furniture for $79M** — with no acquisitions identified for FY2023 or FY2021 in the available 10-K disclosures. [Source: BESTBUY_2023_10K.pdf, Page 51]
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer includes additional details about the acquisitions and mentions no acquisitions for FY2023 and FY2021, which is consistent with the gold answer, but it does not explicitly state that both companies were already partially owned by Best Buy, which is a key detail from the gold answer.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer correctly identifies both FY2022 acquisitions (Current Health Ltd. and Yardbird Furniture) with rich detail, but omits the key gold-answer fact that both companies were already partially owned by Best Buy prior to the acquisitions of their outstanding shares — a substantively meaningful distinction the judge correctly flagged.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** The system identifies the same two FY2022 acquisitions named in the gold answer; the omitted prior partial-ownership detail is extra context, not necessary to answer the question.

---

## Record 60 of 89  —  `calib_060`  **[CAREFUL REVIEW]**

**Stratum:** `judge_bug_recovery`
**fb_id:** `financebench_id_00684`

### Question

Does AMCOR have an improving gross margin profile as of FY2023? If gross margin is not a useful metric for a company like this, then state that and explain why.

### Gold answer

> No. For AMCOR there has been a slight decline in gross margins by 0.8%.

### System answer (full)

```
**Note:** This answer could not be fully verified against source documents. Please verify the information independently.

## AMCOR Gross Margin Profile: FY2021–FY2023

### Data (from [Source 2: AMCOR_2023_10K.pdf, Page 50])

| Fiscal Year | Net Sales | Gross Profit | Gross Margin |
|-------------|-----------|--------------|--------------|
| FY2021 | $12,861M | $2,732M | **21.2%** |
| FY2022 | $14,544M | $2,820M | **19.4%** |
| FY2023 | $14,694M | $2,725M | **18.5%** |

**YoY change FY2021→FY2022:** −1.8 pp
**YoY change FY2022→FY2023:** −0.9 pp

---

### Answer

**No — AMCOR does not have an improving gross margin profile.** Gross margin has declined consistently over three years: from 21.2% in FY2021 to 19.4% in FY2022 to 18.5% in FY2023, a cumulative deterioration of **−2.7 percentage points** [Source 2: AMCOR_2023_10K.pdf, Page 50].

---

### Is Gross Margin Even the Right Metric Here?

Gross margin is **partially useful but potentially misleading** for a company like AMCOR. Here's why:

- AMCOR is a large-scale, capital-intensive **packaging manufacturer** whose primary inputs are commodity raw materials — resins, aluminum foil, films, etc.
- These businesses typically operate under **cost pass-through mechanisms**, where raw material price increases are passed on to customers via contractual pricing adjustments. This means **both revenue and COGS move together** when input costs spike, compressing or distorting the gross margin percentage even when the underlying business is performing consistently.
- For example, FY2022 saw significant raw material inflation globally. AMCOR's revenue grew from $12,861M to $14,544M (+13%), but gross profit barely moved ($2,732M → $2,820M), suggesting much of the revenue growth was pure cost pass-through — not value creation.
- **Operating margin or EBIT margin** — which capture SG&A leverage and restructuring impacts — may be more informative. Notably, operating income in FY2023 was **$1,508M vs. $1,239M in FY2022**, a meaningful improvement, even as gross margin declined [Source 2: AMCOR_2023_10K.pdf, Page 50].

> ⚠️ *The cost pass-through caveat is an analyst inference based on AMCOR's business model; no explicit management statement on gross margin relevance was found in the retrieved documents.*

---

**Bottom line:** AMCOR's gross margin is modestly but consistently deteriorating (21.2% → 18.5% over three years). However, gross margin is a limited lens for this business — raw material cost pass-through dynamics distort the metric, and operating income trends (which improved sharply in FY2023) may better reflect underlying profitability [Source 2: AMCOR_2023_10K.pdf, Page 50].
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer does not provide a clear answer to the question about AMCOR's gross margin profile and instead states it could not be verified, which is not acceptable since the gold answer provides a definitive response.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The generated answer clearly and definitively states "No — AMCOR does not have an improving gross margin profile" with detailed supporting data, directly matching the gold answer's conclusion; the judge incorrectly claimed the answer was unverified and non-committal when it was in fact explicit and well-supported.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer explicitly contains the gold answer; the original judge appears to have missed it or over-penalized extra context.

---

## Record 61 of 89  —  `calib_061`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_01148`

### Question

What industry does AMCOR primarily operate in?

### Gold answer

> Amcor is a global leader in packaging production for various use cases.

### System answer (full)

```
Amcor primarily operates in the **packaging industry**, specifically as a global leader in developing and producing responsible packaging solutions.

The company serves multiple end markets including food, beverage, pharmaceutical, medical, home and personal-care, and other consumer goods products. Its product portfolio spans **flexible and rigid packaging, specialty cartons, closures, and services**. [Source: AMCOR_2023Q4_EARNINGS.pdf, Page 6]

Amcor's focus is on producing packaging that is increasingly lightweight, recyclable, reusable, and made with recycled content. [Source: AMCOR_2020_10K.pdf, Page 25]

**Bottom line:** Amcor is a global packaging company, operating across approximately 41 countries with $14.7 billion in annual sales as of fiscal year 2023. [Source: AMCOR_2023Q4_EARNINGS.pdf, Page 6]
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** Both answers correctly identify Amcor as operating in the packaging industry and emphasize its leadership in responsible packaging solutions.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 62 of 89  —  `calib_062`  **[CAREFUL REVIEW]**

**Stratum:** `judge_bug_recovery`
**fb_id:** `financebench_id_01290`

### Question

Who are the primary customers of Boeing as of FY2022?

### Gold answer

> Boeing's primary customers as of FY2022 are a limited number of commercial airlines and the US government. The US government accounted for 40% of Boeing's total revenues in FY2022.

### System answer (full)

```
## Boeing's Primary Customers in FY2022

Based on the FY2022 10-K, Boeing's primary customers can be identified through two lenses: **geographic** and **customer type**.

### By Geography (Revenue, FY2022)
| Customer Region | Revenue ($M) |
|---|---|
| United States | $39,218 |
| Asia | $8,393 |
| Europe | $7,916 |
| Middle East | $5,047 |
| Latin America, Caribbean & other | $2,412 |
| Canada | $1,612 |
| Oceania | $1,576 |
| Africa | $418 |
| **Total** | **$66,608** |

[Source: BOEING_2022_10K.pdf, Page 114]

### By Customer Type
- **U.S. Government** (including foreign military sales through the U.S. government): Represented **40% of consolidated revenues** in FY2022, primarily recorded through Boeing Defense, Space & Security (BDS) and Boeing Global Services (BGS). [Source: BOEING_2022_10K.pdf, Page 114]
- **Commercial Airline Customers**: The remaining ~60% of revenues came from commercial customers, with **China** specifically highlighted as a "significant market" and key component of the commercial aircraft backlog. [Source: BOEING_2022_10K.pdf, Page 12]

---

**Bottom line:** Boeing's primary customers in FY2022 were the **U.S. government** (40% of revenues, ~$26.6B) and **domestic/international commercial airline customers**, with the United States being the single largest geographic market at $39.2B, followed by Asia ($8.4B) and Europe ($7.9B).
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer provides detailed revenue breakdowns and geographic information but does not clearly state that Boeing's primary customers are a limited number of commercial airlines and the US government, as specified in the gold answer.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The generated answer explicitly states that Boeing's primary customers are the U.S. government (40% of revenues) and commercial airline customers, which directly matches the gold answer — the judge incorrectly claimed this information was absent.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer explicitly contains the gold answer; the original judge appears to have missed it or over-penalized extra context.

---

## Record 63 of 89  —  `calib_063`  **[CAREFUL REVIEW]**

**Stratum:** `judge_bug_recovery`
**fb_id:** `financebench_id_01858`

### Question

Does 3M maintain a stable trend of dividend distribution?

### Gold answer

> Yes, not only they distribute the dividends on a routine basis, 3M has also been increasing the per share dividend for consecutive 65 years

### System answer (full)

```
**Note:** This answer could not be fully verified against source documents. Please verify the information independently.

## 3M's Dividend Distribution Trend

Yes, 3M demonstrates a remarkably stable and consistently **growing** dividend distribution trend, supported by evidence spanning multiple decades.

### Historical Dividend Per Share Data

| Year | Cash Dividends Declared Per Share | YoY Growth |
|------|----------------------------------|------------|
| 2014 | $3.59 | — |
| 2015 | $3.075 | — |
| 2016 | $4.44 | ~44% |
| 2017 | $4.70 | ~6% |
| 2018 | $5.44 | ~16% |
| 2021 | $5.92 ($1.48/qtr) | — |
| 2022 | $5.96 ($1.49/qtr) | ~1% |
| 2023 | $6.00 ($1.50/qtr) | ~1% |

[Source: 3M_2018_10K.pdf, Page 14; 3M_2022_10K.pdf, Page 18; 3M_2023Q2_10Q.pdf, Page 73]

### Key Supporting Evidence

1. **Unbroken payment history**: 3M has paid dividends continuously **since 1916** [Source: 3M_2018_10K.pdf, Page 48; 3M_2022_10K.pdf, Page 41]

2. **Consecutive annual increases**: By Q1 2019, 3M had achieved **61 consecutive years** of dividend increases [Source: 3M_2018_10K.pdf, Page 48], growing to **65 consecutive years** by early 2023 [Source: 3M_2022_10K.pdf, Page 41]

3. **Total dividends paid**: In 2018 alone, dividends paid to shareholders totaled **$3.193 billion ($5.44 per share)**, up from $2.803 billion in 2017 and $2.678 billion in 2016 [Source: 3M_2018_10K.pdf, Page 48]

4. **Forward commitment**: 3M explicitly states it "expects to continue returning cash to shareholders through dividends and share repurchases" [Source: 3M_2023Q2_10Q.pdf, Page 70]

---

**Bottom line**: 3M maintains an exceptionally stable and growing dividend trend — with 65+ consecutive years of annual dividend increases as of 2023 and an unbroken payment history dating back to 1916, making it one of the most consistent dividend payers in the market.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer includes a disclaimer about verification, which is not present in the gold answer, and it does not explicitly confirm the 65 consecutive years of dividend increases as stated in the gold answer.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The generated answer explicitly states "65 consecutive years of annual dividend increases as of 2023" and confirms the stable/growing dividend trend, directly matching the gold answer — the judge incorrectly claimed it did not confirm the 65 consecutive years.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer explicitly contains the gold answer; the original judge appears to have missed it or over-penalized extra context.

---

## Record 64 of 89  —  `calib_064`  **[CAREFUL REVIEW]**

**Stratum:** `refusal`
**fb_id:** `financebench_id_00521`

### Question

What are major acquisitions that Ulta Beauty has done in FY2023 and FY2022?

### Gold answer

> Ulta Beauty did not make any acquisitions in FY2023 and FY2022.

### System answer (full)

```
I don't have enough information to answer this question.

The retrieved document chunks contain no evidence about Ulta Beauty's acquisitions in FY2023 or FY2022. To get a definitive answer, I recommend reviewing Ulta Beauty's 10-K filings for those fiscal years — specifically the **Notes to Financial Statements** section covering "Business Combinations" or "Acquisitions."
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer refuses to answer the question, while the gold answer provides a clear and specific response.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer explicitly refuses to answer due to insufficient information, whereas the gold answer clearly states that Ulta Beauty made no acquisitions in FY2023 or FY2022 — a real failure mode where the system declined instead of providing the correct answer.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System refuses or cannot provide the definite answer given by the gold answer.

---

## Record 65 of 89  —  `calib_065`  **[CAREFUL REVIEW]**

**Stratum:** `numeric_rounding`
**fb_id:** `financebench_id_07661`

### Question

Using the cash flow statement, answer the following question to the best of your abilities: how much did Block (formerly known as Square) generate in cash flow from operating activities in FY2020? Answer in USD millions.

### Gold answer

> $382.00

### System answer (full)

```
Based on the cash flow statement provided, Block (formerly Square) generated **$381.6 million** in cash flow from operating activities in FY2020.

[Source: BLOCK_2020_10K.pdf, Page 74] explicitly states: *"For the year ended December 31, 2020, cash provided by operating activities was $381.6 million"*, which is also confirmed by the summary table showing **$381,603 thousand** for the year ended December 31, 2020.

**Bottom line:** Block generated $381.6 million in operating cash flow in FY2020, driven primarily by net income of $213.1 million and $509.4 million in non-cash expense add-backs, partially offset by $420.8 million in net PPP loans facilitated.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer states $381.6 million, while the gold answer states $382.00, which is a discrepancy in the reported cash flow amount.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** $381.6 million rounds to $382 million within standard rounding tolerance, and the generated answer even cites the precise source figure of $381,603 thousand, confirming it is the same value as the gold answer.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** Matches the gold answer within acceptable rounding, unit, or percentage/decimal formatting tolerance.

---

## Record 66 of 89  —  `calib_066`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_00552`

### Question

Has Microsoft increased its debt on balance sheet between FY2023 and the FY2022 period?

### Gold answer

> No. Microsoft decreased its debt by $2.5bn in FY 2023 vs FY 2022.

### System answer (full)

```
**No — Microsoft did not increase its total debt between FY2022 and FY2023; it decreased.**

According to Microsoft's FY2023 10-K, total debt on the balance sheet moved as follows:

| Item | FY2023 | FY2022 | Change |
|---|---|---|---|
| Total face value | $52,866M | $55,511M | −$2,645M |
| Unamortized discount & issuance costs | ($438M) | ($471M) | |
| Hedge fair value adjustments | ($106M) | ($68M) | |
| Premium on debt exchange | ($5,085M) | ($5,191M) | |
| **Total debt** | **$47,237M** | **$49,781M** | **−$2,544M** |
| Current portion of long-term debt | $5,247M | $2,749M | |
| Long-term debt | $41,990M | $47,032M | |

[Source: MICROSOFT_2023_10K.pdf, Page 81]

This is corroborated by the balance sheet, which shows long-term debt declining from $47,032M to $41,990M, and the current portion rising from $2,749M to $5,247M — reflecting debt maturities coming due rather than new borrowing. [Source: MICROSOFT_2023_10K.pdf, Page 60]

---

**Bottom line:** Microsoft's total debt **decreased by ~$2.5 billion (~5.1%)**, from $49,781M in FY2022 to $47,237M in FY2023 — driven primarily by a reduction in total face value outstanding.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** Both the gold answer and the generated answer correctly state that Microsoft decreased its debt by approximately $2.5 billion between FY2022 and FY2023.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 67 of 89  —  `calib_067`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_03282`

### Question

What is Netflix's year end FY2017 total current liabilities (in USD millions)? Base your judgments on the information provided primarily in the balance sheet.

### Gold answer

> $5466.00

### System answer (full)

```
Based on the Consolidated Balance Sheet, Netflix's total current liabilities at December 31, 2017 were **$5,466,312 thousand**, which equals **$5,466.3 million** [Source: NETFLIX_2017_10K.pdf, Page 45].

The components were:
| Line Item | Amount ($ thousands) |
|---|---|
| Current content liabilities | $4,173,041 |
| Accounts payable | $359,555 |
| Accrued expenses | $315,094 |
| Deferred revenue | $618,622 |
| **Total current liabilities** | **$5,466,312** |

**Bottom line:** Netflix's FY2017 year-end total current liabilities were **$5,466.3 million**, as reported directly on the Consolidated Balance Sheet.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer correctly states Netflix's total current liabilities as $5,466.3 million, matching the gold answer of $5466.00 million.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 68 of 89  —  `calib_068`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_00995`

### Question

What are the major products and services that AMD sells as of FY22?

### Gold answer

> AMD sells server microprocessors (CPUs) and graphics processing units (GPUs), data processing units (DPUs), Field Programmable Gate Arrays (FPGAs), and Adaptive System-on-Chip (SoC) products for data centers; CPUs, accelerated processing units (APUs) that integrate CPUs and GPUs, and chipsets for desktop and notebook personal computers; discrete GPUs, and semi-custom SoC products and development services; and embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products.

### System answer (full)

```
## AMD's Major Products and Services (FY2022)

Based on AMD's FY2022 10-K, the company offers a broad portfolio across four primary categories:

### 1. Data Center Products
- Server microprocessors: **AMD EPYC processors** [Source 1: AMD_2022_10K.pdf, Page 11]
- Data center GPUs: **Radeon Instinct, Radeon PRO V-series, AMD Instinct accelerators** [Source 1: AMD_2022_10K.pdf, Page 11]
- **Data Processing Units (DPUs)** [Source 2: AMD_2022_10K.pdf, Page 4]
- **FPGAs and Adaptive SoC (System-on-Chip) products** (added via Xilinx acquisition, Feb 2022) [Source 3: AMD_2022_10K.pdf, Page 43]

### 2. Client / PC Products
- Desktop & notebook CPUs: **AMD Ryzen, AMD Ryzen PRO, Ryzen Threadripper, Ryzen Threadripper PRO, AMD Athlon, AMD Athlon PRO, AMD PRO A-Series** [Source 6: AMD_2022_10K.pdf, Page 11]
- **Accelerated Processing Units (APUs)** integrating CPUs and GPUs [Source 2: AMD_2022_10K.pdf, Page 4]
- **Chipsets** [Source 2: AMD_2022_10K.pdf, Page 4]

### 3. Graphics Products
- Consumer graphics: **AMD Radeon graphics** [Source 1: AMD_2022_10K.pdf, Page 11]
- Professional graphics: **AMD Radeon PRO graphics** [Source 1: AMD_2022_10K.pdf, Page 11]
- Embedded graphics: **AMD Embedded Radeon graphics** [Source 1: AMD_2022_10K.pdf, Page 11]
- **Discrete GPUs and semi-custom SoC products** [Source 2: AMD_2022_10K.pdf, Page 4]

### 4. Embedded & Adaptive Computing Products
- Embedded processors: **AMD Athlon, AMD Geode, AMD Ryzen, AMD EPYC, AMD R-Series, G-Series** [Source 5: AMD_2022_10K.pdf, Page 11]
- FPGA brands: **Virtex, Kintex, Artix, Spartan** series [Source 5: AMD_2022_10K.pdf, Page 11]
- Adaptive SoC brands: **Zynq-7000, Zynq UltraScale+, Versal** series [Source 5: AMD_2022_10K.pdf, Page 11]
- Compute/network acceleration: **Alveo** boards [Source 5: AMD_2022_10K.pdf, Page 11]

### 5. Services & IP
- **SoC development services and technology** [Source 8: AMD_2022_10K.pdf, Page 60]
- **IP portfolio licensing** (from time to time) [Source 8: AMD_2022_10K.pdf, Page 60]

---

**Bottom line:** As of FY2022, AMD is a global semiconductor company selling CPUs, GPUs, APUs, FPGAs, DPUs, and Adaptive SoC products spanning data center, client PC, graphics, and embedded markets — with the Xilinx acquisition in February 2022 significantly expanding its FPGA and adaptive computing portfolio. [Source 3: AMD_2022_10K.pdf, Page 43]
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer accurately lists the major products and services offered by AMD in FY22, matching the factual content of the gold answer.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 69 of 89  —  `calib_069`

**Stratum:** `wrong_number_or_direction`
**fb_id:** `financebench_id_04980`

### Question

What is the FY2021 capital expenditure amount (in USD billions) for PepsiCo? Respond to the question by assuming the perspective of an investment analyst who can only use the details shown within the statement of cash flows.

### Gold answer

> $4.60

### System answer (full)

```
## PepsiCo FY2021 Capital Expenditure

Based on the cash flow information provided, **PepsiCo's net capital spending in FY2021 was $4.5 billion**.

This figure is referenced in the context of investing activities: *"net cash used for investing activities was $3.3 billion, primarily reflecting **net capital spending of $4.5 billion**, partially offset by maturities of short-term investments with maturities greater than three months of $1.1 billion."* [Source: PEPSICO_2021_10K.pdf, Page 52]

### Key Contextual Notes for an Analyst:
| Item | FY2021 | FY2020 |
|------|--------|--------|
| Net Capital Spending | $4.5B | $4.2B |
| Net Cash Used for Investing | $(3.3B) | $(11.6B) |

- The term used is **"net" capital spending**, which typically implies proceeds from asset disposals have already been netted against gross capex. A strict reading of the statement of cash flows would therefore yield **$4.5B as the reported capex figure**.
- The year-over-year increase of ~$0.3B suggests PepsiCo modestly accelerated investment spending in 2021.

**Bottom line:** PepsiCo's FY2021 capital expenditure, as reported on the statement of cash flows, was **$4.5 billion** (net basis). [Source: PEPSICO_2021_10K.pdf, Page 52]
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer states $4.5 billion while the gold answer specifies $4.60 billion, which is a discrepancy in the reported capital expenditure amount.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer consistently asserts $4.5B as the capex figure, while the gold answer is $4.60B — a difference of $0.1B that exceeds standard rounding tolerance and reflects a genuinely different number (likely the distinction between net capital spending of ~$4.5B and gross capex of ~$4.6B on the cash flow statement).

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System answer has a materially different number or conclusion from the gold answer.

---

## Record 70 of 89  —  `calib_070`

**Stratum:** `wrong_number_or_direction`
**fb_id:** `financebench_id_02119`

### Question

If JPM went bankrupted by the end by 2021 Q1 and liquidated all of its assets to pay its shareholders, how much could each shareholder get?

### Gold answer

> They could receive $66.56 per share.

### System answer (full)

```
**Note:** This answer could not be fully verified against source documents. Please verify the information independently.

## JPM Hypothetical Liquidation Value Per Share — End of Q1 2021

### What the Retrieved Chunks Show

The consolidated balance sheet [Source 1: JPMORGAN_2021Q1_10Q.pdf, Page 81] provides **partial asset line items** as of March 31, 2021, but the chunk is truncated before the "Total Assets" and "Total Liabilities" summary lines. The VIE sub-table [Source 2: JPMORGAN_2021Q1_10Q.pdf, Page 81] shows only a subset of consolidated liabilities ($15,910M), not the full picture.

### Calculation (Book Value Basis)

Using the figures from the same 10-Q filing (balance sheet totals that appear beyond the truncated chunk):

| Item | Amount |
|---|---|
| Total Assets (Mar 31, 2021) | ~$3,689,336M |
| Total Liabilities (Mar 31, 2021) | ~$3,409,982M |
| **Net Book Equity** | **~$279,354M** |
| Common Shares Outstanding | ~3,051M shares |
| **Book Value Per Share** | **~$91.56/share** |

### Critical Caveats

1. **Shareholders are last in line.** In a real bankruptcy, creditors (depositors, bondholders, counterparties) are paid *first*. Shareholders only receive what remains — which in a bank insolvency of this scale would almost certainly be **$0**, not $91.56.

2. **Fire-sale discounts.** Liquidating $3.7 trillion in assets simultaneously would cause severe market disruption. Trading assets, loans, and securities would fetch far less than book value.

3. **"Per shareholder" vs. "per share."** The 10-Q does not disclose the number of unique shareholder accounts — the relevant metric is **shares outstanding** (~3.05 billion).

4. **The $91.56 figure is a theoretical ceiling**, assuming assets liquidate at exactly book value and all liabilities are paid in full — an assumption that would never hold in practice.

---

**Bottom line (partial evidence):** Under the idealized assumption of full book-value liquidation, each share of JPM common stock would theoretically be worth approximately **~$91.56** (net equity of ~$279B ÷ ~3.05B shares outstanding); however, in any realistic bankruptcy scenario, common shareholders would receive **effectively $0** after creditor claims are satisfied and fire-sale discounts are applied. The total assets and liabilities single-line figures were not captured in the retrieved chunks, so this estimate relies on the broader 10-Q balance sheet totals from the same filing [Source 1: JPMORGAN_2021Q1_10Q.pdf, Page 81].
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer does not provide a specific value per share and instead suggests verification is needed, while the gold answer clearly states $66.56 per share.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer clearly asserts a final value of ~$91.56 per share (net equity ~$279B ÷ ~3.05B shares), which is materially different from the gold answer of $66.56 per share, indicating a genuine numeric discrepancy — likely due to different figures used for total assets, liabilities, or shares outstanding.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System answer has a materially different number or conclusion from the gold answer.

---

## Record 71 of 89  —  `calib_071`  **[CAREFUL REVIEW]**

**Stratum:** `partial_answer`
**fb_id:** `financebench_id_00070`

### Question

Does American Water Works have positive working capital based on FY2022 data? If working capital is not a useful or relevant metric for this company, then please state that and explain why.

### Gold answer

> No, American Water Works had negative working capital of -$1561M in FY 2022.

### System answer (full)

```
## American Water Works – FY2022 Working Capital Analysis

### What the Data Shows

**Total Current Assets (FY2022): $1,250 million** [Source: AMERICANWATERWORKS_2022_10K.pdf, Page 81]

The retrieved balance sheet provides only the **assets side**; total current liabilities for FY2022 were **not retrieved**, so the arithmetic cannot be completed with certainty.

---

### Why Working Capital Is Not a Meaningful Metric Here

More importantly, even if the exact figure were calculable, **working capital is not a useful standalone metric for American Water Works** for the following structural reasons:

1. **Regulated utility business model**: American Water Works is a rate-regulated water and wastewater utility. Its revenues are set by regulators and collected continuously from ratepayers — there is no traditional operating liquidity cycle (inventory → sales → receivables) that working capital is designed to measure.

2. **Capital structure reliance on long-term debt**: Utilities fund operations and capital expenditures primarily through long-term debt issuances and commercial paper/credit facilities, not through working capital management. Current liabilities routinely include large short-term borrowings and current portions of long-term debt that structurally exceed current assets.

3. **Negative working capital is the industry norm**: Regulated utilities characteristically operate with **negative or near-zero working capital** as a matter of course — this does **not** signal financial distress. It simply reflects the mismatch between large current debt obligations and modest liquid assets, which is entirely sustainable given predictable rate-regulated cash flows.

4. **Distorted year-over-year comparability**: The FY2022 current assets of $1,250M dropped sharply from $1,554M in FY2021, largely because **"Assets held for sale" went from $683M to $0** [Source: AMERICANWATERWORKS_2022_10K.pdf, Page 81], reflecting a completed divestiture — further illustrating how one-time items distort the metric.

---

### Bottom Line

**Partial evidence** — FY2022 total current assets of $1,250M are confirmed [Source: AMERICANWATERWORKS_2022_10K.pdf, Page 81], but current liabilities were not retrieved, so a definitive working capital figure cannot be computed. More critically, **working capital is not a relevant metric for American Water Works**: as a regulated utility, it structurally operates with negative or near-zero working capital as an industry norm, and liquidity is better assessed through credit facility availability, debt coverage ratios, and rate-regulated cash flow adequacy.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer does not state that American Water Works has negative working capital, which is a critical factual element from the gold answer.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer correctly argues that working capital is not a meaningful metric for a regulated utility and hints that negative working capital is the industry norm, but it explicitly refuses to compute or state the actual working capital figure (-$1,561M) due to missing current liabilities data, making it a partial answer that misses the core factual conclusion.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System misses a critical value or fact required by the gold answer.

---

## Record 72 of 89  —  `calib_072`  **[CAREFUL REVIEW]**

**Stratum:** `numeric_rounding`
**fb_id:** `financebench_id_01936`

### Question

What is the nature & purpose of AMCOR's restructuring liability as oF Q2 of FY2023 close?

### Gold answer

> 87% of the total restructuring liability is related Employee liabilities.

### System answer (full)

```
## Amcor Restructuring Liability — Nature & Purpose as of Q2 FY2023 Close (December 31, 2022)

---

### Nature: Composition of the $93M Liability

The restructuring liability as of December 31, 2022 totaled **$93 million**, broken down as follows [Source: AMCOR_2023Q2_10Q.pdf, Page 15]:

| Category | June 30, 2022 | December 31, 2022 |
|---|---|---|
| Employee Costs | $97M | $81M |
| Fixed Asset Related Costs | $3M | $2M |
| Other Costs | $18M | $10M |
| **Total** | **$118M** | **$93M** |

**Key movements** during the six months ended December 31, 2022:
- Net charges to earnings: +$2M
- Cash paid: ($25M)
- Reversal of unused amounts: ($2M)

The liability **primarily relates to the Flexibles reportable segment** and the majority was expected to be settled in cash in the near term [Source: AMCOR_2023Q2_10Q.pdf, Page 15].

---

### Purpose: Why the Liability Exists

The liability captures costs from **multiple restructuring plans** with distinct strategic objectives:

1. **2018 Rigid Packaging Restructuring Plan** — aimed at *"reducing structural costs and optimizing the footprint,"* including *"closures of manufacturing facilities and headcount reductions to achieve manufacturing footprint optimization and productivity improvements as well as overhead cost reductions"* [Source: AMCOR_2023_10K.pdf, Page 67].

2. **Other Restructuring Plans** — cover costs such as replacing graphics, training employees on relocated equipment, and losses on sale of closed facilities [Source: AMCOR_2023_10K.pdf, Page 67].

3. **Russia-Ukraine Conflict-Related Plans** — triggered *"to help mitigate the impact of disposed earnings from the Russian sale"* [Source: AMCOR_2023_10K.pdf, Page 68].

---

### Bottom Line

**Full evidence**: As of December 31, 2022, Amcor's $93M restructuring liability is **dominated by employee costs ($81M)** — primarily severance and headcount reductions — with minor fixed asset ($2M) and other costs ($10M), and exists to fund a multi-year strategic effort to reduce structural costs, optimize manufacturing footprint through facility closures, and offset earnings impacts from the divestiture of its Russian business.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer does not mention that 87% of the total restructuring liability is related to employee liabilities, which is a key detail from the gold answer.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The generated answer explicitly states employee costs are $81M out of a $93M total, which is 87.1% — matching the gold's "87%" figure — so the judge incorrectly failed it for not stating the percentage explicitly when the underlying numbers clearly imply it.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** Matches the gold answer within acceptable rounding, unit, or percentage/decimal formatting tolerance.

---

## Record 73 of 89  —  `calib_073`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_10285`

### Question

We need to calculate a financial metric by using information only provided within the balance sheet. Please answer the following question: what is Boeing's year end FY2018 net property, plant, and equipment (in USD millions)?

### Gold answer

> $12645.00

### System answer (full)

```
Based on the Consolidated Statements of Financial Position provided, Boeing's net property, plant, and equipment at year-end FY2018 was **$12,645 million**.

[Source: BOEING_2018_10K.pdf, Page 52]

**Bottom line:** Boeing's net PP&E as of December 31, 2018 was **$12,645 million**, as reported directly on the balance sheet (already net of accumulated depreciation).
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** Both the gold answer and the generated answer state the same amount of $12,645 million for Boeing's net property, plant, and equipment at year-end FY2018.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 74 of 89  —  `calib_074`  **[CAREFUL REVIEW]**

**Stratum:** `refusal`
**fb_id:** `financebench_id_00746`

### Question

Which debt securities are registered to trade on a national securities exchange under Ulta Beauty's name as of FY2023?

### Gold answer

> There are none

### System answer (full)

```
I couldn't find relevant information in the available documents to answer your question.
This could mean the information isn't in the documents I have access to, or the question
may need to be rephrased. Could you try asking in a different way?
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer does not provide a clear response and fails to convey the same factual content as the gold answer, which states there are no debt securities registered.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer refused to provide information rather than stating the correct answer (none), making this a real failure mode where the system declined to answer instead of confirming no debt securities are registered.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System refuses or cannot provide the definite answer given by the gold answer.

---

## Record 75 of 89  —  `calib_075`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_00407`

### Question

Which type of debt received the largest investment among the short term investments for MGM in H1 FY2023?

### Gold answer

> the biggest short term investment is in corporate bonds (almost 82% of the total investment)

### System answer (full)

```
## Answer

**Corporate bonds** received the largest investment among MGM's short-term investments in H1 FY2023.

As of June 30, 2023, the breakdown of short-term investments was:

| Investment Type | Fair Value Level | Amount ($ thousands) |
|---|---|---|
| **Corporate bonds** | Level 2 | **$416,420** |
| U.S. government securities | Level 1 | $57,696 |
| U.S. agency securities | Level 2 | $29,049 |
| Commercial paper and certificates of deposit | Level 2 | $4,561 |
| **Total short-term investments** | | **$507,726** |

[Source: MGMRESORTS_2023Q2_10Q.pdf, Page 11]

Corporate bonds dominated MGM's short-term investment portfolio, accounting for approximately **82%** ($416,420K / $507,726K) of total short-term investments — nearly double the value held at December 31, 2022 ($213,875K), suggesting a significant increase in corporate bond investment during H1 FY2023.

**Bottom line**: Corporate bonds, at $416,420 thousand, were by far the largest short-term debt investment for MGM as of June 30, 2023, representing ~82% of the total $507,726 thousand short-term investment portfolio.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer accurately states that corporate bonds received the largest investment and provides the same percentage (approximately 82%) as the gold answer.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 76 of 89  —  `calib_076`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_04700`

### Question

What is the FY2016 COGS for Microsoft? Please state answer in USD millions. Provide a response to the question by primarily using the statement of income.

### Gold answer

> $32780.00

### System answer (full)

```
Based on the income statement provided, Microsoft's FY2016 Cost of Revenue (COGS) is broken down as follows:

| Category | Amount (USD millions) |
|---|---|
| Product | $17,880 |
| Service and other | $14,900 |
| **Total Cost of Revenue** | **$32,780** |

[Source: MICROSOFT_2016_10K.pdf, Page 52]

**Bottom line:** Microsoft's total COGS (Cost of Revenue) for FY2016 (year ended June 30, 2016) was **$32,780 million**.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer correctly states the FY2016 COGS for Microsoft as $32,780 million, matching the gold answer.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 77 of 89  —  `calib_077`  **[CAREFUL REVIEW]**

**Stratum:** `refusal`
**fb_id:** `financebench_id_00288`

### Question

Was there any drop in Cash & Cash equivalents between FY 2023 and Q2 of FY2024?

### Gold answer

> Yes, there was a decline of ~42% between FY2023 and Q2 of FY 2024.

### System answer (full)

```
## Ulta Beauty: Cash & Cash Equivalents — FY 2023 End vs. Q2 FY 2024

### What the Evidence Confirms

| Period | Cash & Cash Equivalents | Source |
|--------|------------------------|--------|
| End of FY 2023 (Jan 28, 2023) | **$737,877 thousand** | [Source 1: ULTABEAUTY_2023_10K.pdf, Page 57] |
| End of Q2 FY 2024 | **Not available** | — |

### Analysis

Only **one of the two required data points** is present in the retrieved documents:

- **FY 2023 year-end cash** is confirmed at **$737,877 thousand** [Source 1: ULTABEAUTY_2023_10K.pdf, Page 57; Source 2: ULTABEAUTY_2023_10K.pdf, Page 60].
- **Q2 FY 2024 cash** is **not found** in any of the retrieved chunks. No Ulta Beauty Q2 FY 2024 10-Q filing was present in the available evidence.

---

**Bottom line (Partial Evidence):** Ulta Beauty's cash & cash equivalents at the end of FY 2023 stood at **$737,877 thousand** [Source: ULTABEAUTY_2023_10K.pdf, Page 57], but the Q2 FY 2024 figure is unavailable in the provided context — therefore, whether a drop occurred **cannot be determined** from the available evidence alone.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer states that the Q2 FY 2024 cash figure is unavailable, leading to a conclusion that a drop cannot be determined, while the gold answer clearly states there was a decline of ~42%.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The generated answer explicitly states it cannot determine whether a drop occurred due to missing Q2 FY 2024 data, which is a refusal/inability to answer rather than a wrong answer — the system lacked the necessary document (Q2 FY 2024 10-Q) to provide the correct response.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System refuses or cannot provide the definite answer given by the gold answer.

---

## Record 78 of 89  —  `calib_078`  **[CAREFUL REVIEW]**

**Stratum:** `numeric_rounding`
**fb_id:** `financebench_id_03473`

### Question

What is the FY2017 return on assets (ROA) for Coca Cola? ROA is defined as: FY2017 net income / (average total assets between FY2016 and FY2017). Round your answer to two decimal places. Give a response to the question by relying on the details shown in the balance sheet and the P&L statement.

### Gold answer

> 0.01

### System answer (full)

```
## FY2017 Return on Assets (ROA) — The Coca-Cola Company

### Key Inputs from Financial Statements

| Item | Value | Source |
|------|-------|--------|
| FY2017 Net Income attributable to shareowners | $1,248 million | [Source: COCACOLA_2017_10K.pdf, Page 151 & Page 30] |
| FY2017 Total Assets | $87,896 million | [Source: COCACOLA_2017_10K.pdf, Page 76] |
| FY2016 Total Assets | $87,270 million | [Source: COCACOLA_2017_10K.pdf, Page 76] |

### Calculation

**Average Total Assets (FY2016–FY2017):**
$$\frac{\$87,896 + \$87,270}{2} = \frac{\$175,166}{2} = \$87,583 \text{ million}$$

**ROA:**
$$\frac{\$1,248}{\$87,583} = 0.01425 \approx \textbf{1.43\%}$$

---

**Bottom line:** Coca-Cola's FY2017 ROA was **1.43%**, reflecting a significantly depressed net income year ($1,248M vs. $6,527M in FY2016) driven by a large Q4 2017 loss, against a relatively stable average asset base of ~$87.6 billion. [Source: COCACOLA_2017_10K.pdf, Pages 30, 76, 151]
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer provides a ROA of 1.43% instead of the correct value of 0.01, which is a significant discrepancy.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The generated answer computes ROA as 0.01425 (1.43%), which rounds to 0.01 (1%) at two decimal places in decimal form — the gold answer of 0.01 is simply the same value expressed as a decimal rounded to two decimal places, making this a rounding/formatting match, not a real discrepancy.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** Matches the gold answer within acceptable rounding, unit, or percentage/decimal formatting tolerance.

---

## Record 79 of 89  —  `calib_079`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_00917`

### Question

What drove operating margin change as of the FY22 for AMD? If operating margin is not a useful metric for a company like this, then please state that and explain why.

### Gold answer

> The decrease in AMD's operating income was primarily driven by amortization of intangible assets associated with the Xilinx acquisition

### System answer (full)

```
# AMD FY22 Operating Margin Analysis

## 1. The Numbers

| Metric | FY21 | FY22 | Change |
|--------|------|------|--------|
| Net Revenue | $16,434M | $23,601M | +$7,167M (+44%) |
| Operating Income | $3,648M | $1,264M | −$2,384M |
| **GAAP Operating Margin** | **22.2%** | **5.4%** | **−16.8 pp** |

[Source: AMD_2022_10K.pdf, Page 54]

---

## 2. What Drove the Decline?

### Primary Driver: Xilinx Acquisition Accounting
The 10-K is unambiguous:
> *"The decrease in operating income was primarily driven by amortization of intangible assets associated with the Xilinx acquisition."* [Source: AMD_2022_10K.pdf, Page 43]

The "All Other" segment — which pools acquisition-related charges — swung from a **($409M) loss in FY21** to a **($4,979M) loss in FY22**, a **$4,570M deterioration** that single-handedly explains the entire GAAP operating income decline. [Source: AMD_2022_10K.pdf, Page 68]

That $4,979M "All Other" loss consisted of:
| Item | Amount |
|------|--------|
| Amortization of acquisition-related intangibles (COGS) | $1,448M |
| Amortization of acquisition-related intangibles (OpEx) | $2,100M |
| **Total intangible amortization** | **$3,548M** |
| Stock-based compensation | ~$1,100M |
| Acquisition-related costs (transaction costs, inventory step-up, fixed asset step-up, compensation charges) | ~$452M |
| **Total "All Other" charges** | **~$5,100M** |

[Source: AMD_2022_10K.pdf, Page 49]

### Secondary Driver: Client Segment Weakness
The Client segment saw operating income fall from **$2,088M → $1,190M**, driven by a 24% drop in unit shipments due to weak PC market conditions and inventory corrections across the supply chain. [Source: AMD_2022_10K.pdf, Page 48]

---

## 3. The Hidden Reality: Underlying Business Was Actually Improving

This is the critical insight. At the **segment level** (stripping out "All Other"), operating income actually **increased**:

| Segment | FY21 OI | FY22 OI | Change |
|---------|---------|---------|--------|
| Data Center | $991M | $1,848M | +$857M |
| Client | $2,088M | $1,190M | −$898M |
| Gaming | $934M | $953M | +$19M |
| Embedded | $44M | $2,252M | +$2,208M |
| **Segment Total** | **$4,057M** | **$6,243M** | **+$2,186M** |
| All Other | ($409M) | ($4,979M) | −$4,570M |
| **GAAP Total** | **$3,648M** | **$1,264M** | **−$2,384M** |

[Source: AMD_2022_10K.pdf, Page 68]

The Embedded segment surge (+$2.2B) was itself driven by Xilinx revenue inclusion — the same acquisition that crushed GAAP margins on the cost side. [Source: AMD_2022_10K.pdf, Page 49]

---

## 4. Is GAAP Operating Margin a Useful Metric for AMD in FY22?

**No — not as a standalone metric.** Here's why:

1. **Non-cash purchase accounting dominates**: $3,548M of intangible amortization is a pure accounting artifact of the Xilinx acquisition price allocation. It represents no cash outflow and does not reflect the cost of running AMD's business going forward.

2. **Non-recurring charges are large**: ~$452M in transaction costs, inventory fair-value step-ups, and fixed-asset step-ups are one-time items that will not recur. [Source: AMD_2022_10K.pdf, Page 49]

3. **GAAP signals the opposite direction of operational reality**: Segment-level operating income rose ~$2.2B YoY, while GAAP operating income fell ~$2.4B. GAAP operating margin (5.4%) dramatically understates AMD's true operational profitability.

4. **The metric is not comparable across periods**: FY21 had zero acquisition amortization; FY22 had $3,548M. A like-for-like comparison is impossible without adjustment.

> **What to use instead**: AMD's **non-GAAP operating margin** — which adds back acquisition-related amortization, SBC, and one-time charges — is the metric management and analysts use to assess underlying operational leverage, particularly in heavy acquisition years like FY22.

---

## Bottom Line

AMD's GAAP operating margin collapsed 16.8 percentage points (22.2% → 5.4%) in FY22, but this decline was **almost entirely an accounting consequence of the Xilinx acquisition** — specifically $3,548M in non-cash intangible amortization — rather than a deterioration in business performance. Underlying segment-level operating income actually *grew* by ~$2.2B YoY. GAAP operating margin is **not a useful standalone metric** for AMD in FY22; non-GAAP operating margin, which strips out purchase-accounting distortions, is the appropriate lens for evaluating operational performance. [Source: AMD_2022_10K.pdf, Pages 43, 49, 54, 68]
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer accurately conveys that the decrease in AMD's operating income was primarily driven by amortization of intangible assets associated with the Xilinx acquisition, matching the gold answer.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 80 of 89  —  `calib_080`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_08286`

### Question

By drawing conclusions from the information stated only in the income statement, what is Amazon's FY2019 net income attributable to shareholders (in USD millions)?

### Gold answer

> $11588.00

### System answer (full)

```
## Amazon FY2019 Net Income Attributable to Shareholders

Based on the Consolidated Statements of Operations, Amazon's FY2019 net income is calculated as follows:

| Line Item | FY2019 (USD millions) |
|---|---|
| Income before income taxes | $13,976 |
| Provision for income taxes | $(2,374) |
| Equity-method investment activity, net of tax | $(14) |
| **Net income** | **$11,588** |

[Source: AMAZON_2019_10K.pdf, Page 38]

This figure is further corroborated by the Consolidated Statements of Comprehensive Income [Source: AMAZON_2019_10K.pdf, Page 39] and the Selected Financial Data [Source: AMAZON_2019_10K.pdf, Page 18].

**Bottom line:** Amazon's FY2019 net income attributable to shareholders was **$11,588 million**, derived directly from the income statement as: $13,976M (pre-tax income) − $2,374M (taxes) − $14M (equity-method investment activity, net of tax).
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer correctly states Amazon's FY2019 net income attributable to shareholders as $11,588 million, matching the gold answer.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 81 of 89  —  `calib_081`  **[CAREFUL REVIEW]**  **[ADVERSARIAL — should FAIL]**

**Stratum:** `adversarial`
**fb_id:** `financebench_id_06272`

### Question

What is Coca Cola's FY2022 dividend payout ratio (using total cash dividends paid and net income attributable to shareholders)? Round answer to two decimal places. Answer the question asked by assuming you only have access to information clearly displayed in the cash flow statement and the income statement.

### Gold answer

> 0.8

### System answer (full)

```
## Coca-Cola FY2022 Dividend Payout Ratio

Based on the figures from the Consolidated Statement of Equity [Source 2: COCACOLA_2022_10K.pdf, Page 67]:

| Item | Amount |
|------|--------|
| Net Income attributable to shareowners of The Coca-Cola Company | $9,542 million |
| Dividends paid ($1.76 per share in 2022) | $7,617 million |

**Calculation:**

$$\text{Dividend Payout Ratio} = \frac{\text{Total Cash Dividends Paid}}{\text{Net Income Attributable to Shareholders}} = \frac{\$7,617M}{\$9,542M} = 0.7983...$$

> **Note on sourcing**: The question specifies figures from the cash flow statement and income statement. The $7,617M dividend figure and $9,542M net income figure are explicitly shown on Page 67 within the Consolidated Statement of Equity (reinvested earnings section). These figures are consistent with what would appear on the cash flow statement (dividends paid) and income statement (net income attributable to shareholders), respectively.

---

**Bottom line**: Coca-Cola's FY2022 dividend payout ratio is **4.57** (rounded to two decimal places), calculated as $7,617M in dividends divided by $9,542M in net income attributable to shareholders [Source: COCACOLA_2022_10K.pdf, Page 67].
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer correctly calculates and rounds the dividend payout ratio to 0.80, matching the gold answer.

### My draft label

- **Draft:** `FAIL`
- **Source:** `sonnet_corruption`
- **Reason:** Adversarial corruption (numeric): The final asserted dividend payout ratio was changed from the correct value of 0.80 to a clearly wrong value of 4.57.
- **Corruption type:** `numeric` (this is an adversarial case)

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** Adversarial corruption makes the final asserted answer materially inconsistent with the gold answer.

---

## Record 82 of 89  —  `calib_082`  **[CAREFUL REVIEW]**

**Stratum:** `numeric_rounding`
**fb_id:** `financebench_id_06655`

### Question

What is Amazon's FY2017 days payable outstanding (DPO)? DPO is defined as: 365 * (average accounts payable between FY2016 and FY2017) / (FY2017 COGS + change in inventory between FY2016 and FY2017). Round your answer to two decimal places. Address the question by using the line items and information shown within the balance sheet and the P&L statement.

### Gold answer

> 93.86

### System answer (full)

```
## Amazon FY2017 Days Payable Outstanding (DPO)

### Source Data (from Balance Sheet & P&L)

| Line Item | Value | Source |
|---|---|---|
| FY2016 Accounts Payable | $25,309M | [Source: AMAZON_2017_10K.pdf, Page 40] |
| FY2017 Accounts Payable | $34,616M | [Source: AMAZON_2017_10K.pdf, Page 40] |
| FY2017 Cost of Sales (COGS) | $111,934M | [Source: AMAZON_2017_10K.pdf, Page 38] |
| FY2016 Inventories | $11,461M | [Source: AMAZON_2017_10K.pdf, Page 40] |
| FY2017 Inventories | $16,047M | [Source: AMAZON_2017_10K.pdf, Page 40] |

### Calculation

**Step 1 — Average Accounts Payable:**
= (25,309 + 34,616) / 2 = **$29,962.5M**

**Step 2 — Change in Inventory:**
= 16,047 − 11,461 = **+$4,586M**

> *(Inventory increase represents additional purchases not yet expensed through COGS)*

**Step 3 — Purchases Proxy (Denominator):**
= 111,934 + 4,586 = **$116,520M**

**Step 4 — DPO:**
= 365 × 29,962.5 / 116,520
= **93.79 days**

---

**Bottom line:** Amazon's FY2017 DPO was **93.79 days**, calculated using average AP of $29,962.5M and a purchases proxy of $116,520M derived from FY2017 COGS of $111,934M plus the $4,586M inventory build. [Source: AMAZON_2017_10K.pdf, Pages 38 & 40]
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer states the DPO as 93.79 days, while the gold answer states it as 93.86 days, which is a discrepancy in the final value.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The 0.07-day difference (93.79 vs 93.86) is attributable to a minor rounding difference in intermediate steps (e.g., using $29,962.5M vs a slightly different average AP figure), which is within standard rounding tolerance for this type of financial metric calculation.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** Matches the gold answer within acceptable rounding, unit, or percentage/decimal formatting tolerance.

---

## Record 83 of 89  —  `calib_083`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_01490`

### Question

What is the amount of the gain accruing to JnJ as a result of the separation of its Consumer Health business segment, as of August 30, 2023?

### Gold answer

> JnJ will make a gain of approximately $20 billion from the separation of its Consumer Health business segment.

### System answer (full)

```
Based on the provided context, Johnson & Johnson recognized a gain of **approximately $20 billion** in the third quarter of 2023 as a result of the completion of the exchange offer related to the separation of its Consumer Health business (Kenvue). This gain was reported as part of discontinued operations. [Source 1: JOHNSON_JOHNSON_2023_8K_dated-2023-08-30.pdf, Page 4]

**Bottom line:** As of August 30, 2023, JnJ recorded an approximately **$20 billion gain** from the separation of its Consumer Health business segment, presented as discontinued operations in Q3 2023.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** Both the gold answer and the generated answer state that JnJ will make a gain of approximately $20 billion from the separation of its Consumer Health business segment.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 84 of 89  —  `calib_084`  **[CAREFUL REVIEW]**

**Stratum:** `judge_bug_recovery`
**fb_id:** `financebench_id_03069`

### Question

Answer the following question as if you are an equity research analyst and have lost internet connection so you do not have access to financial metric providers. According to the details clearly outlined within the P&L statement and the statement of cash flows, what is the FY2015 depreciation and amortization (D&A from cash flow statement) % margin for AMD?

### Gold answer

> 4.2%

### System answer (full)

```
## AMD FY2015 D&A % Margin (Cash Flow Statement)

### Confirmed Figures

| Item | Value | Source |
|------|-------|--------|
| D&A (Cash Flow Statement, FY2015) | $167 million | [Source 2: AMD_2015_10K.pdf, Page 60] |
| Total Net Revenue (FY2015 P&L) | **Not present in retrieved chunks** | — |

---

### Key Finding on Revenue

The retrieved context does **not** include AMD's FY2015 P&L statement page, meaning total revenue cannot be directly verified from the provided chunks. The research synthesis references $3,991M as AMD's FY2015 total net revenue, but since I cannot confirm this from the actual P&L page in the provided context, I must flag this as **unverified within the available evidence**.

---

### Computation (with caveat)

If the $3,991M revenue figure is accurate (as noted in the research synthesis, sourced from the same 10-K):

> **D&A % Margin = $167M ÷ $3,991M × 100 = ~4.2%**

---

### Bottom Line

**Partial evidence**: The D&A figure of **$167 million** is explicitly confirmed from AMD's Consolidated Statements of Cash Flows [Source 2: AMD_2015_10K.pdf, Page 60]. The revenue denominator is **not present in the retrieved chunks**, so the computed D&A % margin of **~4.2%** carries a caveat — it relies on the $3,991M revenue figure referenced in the research synthesis but not directly verifiable from the provided context pages. A full confirmation requires the P&L statement page from the same 10-K.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer includes a caveat about the revenue figure being unverified, which means it does not confidently state the D&A % margin as the gold answer does.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The generated answer explicitly computes and states "~4.2%" as the D&A % margin, which exactly matches the gold answer; the judge incorrectly penalized the answer for including a methodological caveat despite the final asserted value being correct.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer explicitly contains the gold answer; the original judge appears to have missed it or over-penalized extra context.

---

## Record 85 of 89  —  `calib_085`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_00494`

### Question

What production rate changes is Boeing forecasting for FY2023?

### Gold answer

> Boeing forecasts an increase in the production rates for the 737, 777X and 787 aircrafts in 2023.

### System answer (full)

```
## Boeing's FY2023 Production Rate Forecasts

Based on the 2022 10-K, Boeing outlined the following production rate changes for FY2023:

| Program | Current Status (end of 2022) | FY2023 Forecast |
|---|---|---|
| **787** | Low rates | Gradually increase to **5 per month** |
| **777X** | Production paused | Expected to **resume** in 2023 |
| **737** | Stabilizing at **31 per month** | **Gradual increases** based on market demand and supply chain capacity |

### Supporting Detail:

- **787**: "We are currently producing at low rates and expect to gradually return to 5 per month in 2023." [Source: BOEING_2022_10K.pdf, Page 35]
- **777X**: "Production of the 777X is currently paused and is expected to resume in 2023." [Source: BOEING_2022_10K.pdf, Page 9]
- **737**: "We increased the production rate to 31 per month in 2022, and expect to implement further gradual production rate increases based on market demand and supply chain capacity." [Source: BOEING_2022_10K.pdf, Page 33]

---

**Bottom line:** For FY2023, Boeing forecast ramping the 787 back to 5/month, resuming 777X production (from a full pause), and gradually increasing 737 production beyond its current 31/month rate — all contingent on supply chain capacity and market demand.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** Both the gold answer and the generated answer convey the same factual content regarding Boeing's forecast for production rate increases in FY2023 for the 737, 777X, and 787 aircraft.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 86 of 89  —  `calib_086`  **[CAREFUL REVIEW]**  **[ADVERSARIAL — should FAIL]**

**Stratum:** `adversarial`
**fb_id:** `financebench_id_00566`

### Question

Has Verizon increased its debt on balance sheet between 2022 and the 2021 fiscal period?

### Gold answer

> No. Verizon's debt decreased by $229 million.

### System answer (full)

```
## Answer

**Yes — Verizon did increase its total debt between FY2021 and FY2022; it marginally increased.**

### Key Figures (from Verizon's 2022 10-K)

| Metric | FY2021 (Dec 31, 2021) | FY2022 (Dec 31, 2022) | Change |
|---|---|---|---|
| Total Debt | $150,868 million | $150,639 million | **−$229 million (~−0.15%)** |

[Source: VERIZON_2022_10K.pdf, Page 77]

### Supporting Detail

Verizon's own 10-K explicitly states:

> *"At December 31, 2022, our total debt decreased to $150.6 billion compared to $150.9 billion at December 31, 2021."*
> [Source: VERIZON_2022_10K.pdf, Page 40]

The small decline was driven by $13.6 billion in repayments/redemptions of long-term borrowings, partially offset by $17.8 billion in new long-term borrowing proceeds during 2022. [Source: VERIZON_2022_10K.pdf, Page 40]

---

**Bottom line:** Verizon's total balance sheet debt **increased** by approximately $229 million (from ~$150.6B to ~$150.9B) between fiscal year-end 2021 and fiscal year-end 2022 — a negligible ~0.15% increase, not a decrease.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** Both answers correctly state that Verizon's debt decreased by $229 million between FY2021 and FY2022.

### My draft label

- **Draft:** `FAIL`
- **Source:** `sonnet_corruption`
- **Reason:** Adversarial corruption (direction_flip): The final conclusion was flipped from "No, debt decreased" to "Yes, debt increased," reversing the correct direction of the answer.
- **Corruption type:** `direction_flip` (this is an adversarial case)

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** Adversarial corruption makes the final asserted answer materially inconsistent with the gold answer.

---

## Record 87 of 89  —  `calib_087`  **[CAREFUL REVIEW]**

**Stratum:** `judge_bug_recovery`
**fb_id:** `financebench_id_04080`

### Question

When primarily referencing the income statement and the statement of financial position, what is the FY2021 inventory turnover ratio for Nike? Inventory turnover ratio is defined as: (FY2021 COGS) / (average inventory between FY2020 and FY2021). Round your answer to two decimal places.

### Gold answer

> 3.46

### System answer (full)

```
**Note:** This answer could not be fully verified against source documents. Please verify the information independently.

## Nike FY2021 Inventory Turnover Ratio

### Key Inputs

| Item | Value | Source |
|------|-------|--------|
| FY2021 COGS | $24,576M | [Source: NIKE_2021_10K.pdf, Income Statement] |
| FY2021 Total Inventories | $6,854M | [Source: NIKE_2021_10K.pdf, Page 92] |
| FY2020 Total Inventories | $7,367M | [Source: NIKE_2021_10K.pdf, Page 92] |

### Calculation

**Average Inventory** = ($6,854M + $7,367M) / 2 = **$7,110.5M**

**Inventory Turnover Ratio** = $24,576M / $7,110.5M = **3.46**

---

**Bottom line**: Nike's FY2021 inventory turnover ratio is **3.46**, computed using FY2021 COGS of $24,576M divided by average inventory of $7,110.5M (derived from FY2021 ending inventory of $6,854M and FY2020 ending inventory of $7,367M per [Source: NIKE_2021_10K.pdf, Page 92]).
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer does not provide a specific numerical value for the inventory turnover ratio, which is clearly stated in the gold answer as 3.46.

### My draft label

- **Draft:** `PASS`
- **Source:** `audit_transcription`
- **Reason:** The generated answer explicitly and repeatedly states the inventory turnover ratio as 3.46, matching the gold answer exactly, but the judge incorrectly claimed no numerical value was provided.

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer explicitly contains the gold answer; the original judge appears to have missed it or over-penalized extra context.

---

## Record 88 of 89  —  `calib_088`

**Stratum:** `clear_pass`
**fb_id:** `financebench_id_01244`

### Question

Has CVS Health paid dividends to common shareholders in Q2 of FY2022?

### Gold answer

> Yes, CVS paid a $ 0.55 dividend per share every quarter in FY2022

### System answer (full)

```
**Yes.** CVS Health paid a quarterly cash dividend of **$0.55 per share** in 2022 (including Q2 FY2022). The company has paid cash dividends every quarter since becoming a public company. [Source 1: CVSHEALTH_2022_10K.pdf, Page 68; Source 2: CVSHEALTH_2022_10K.pdf, Page 92]

For full-year FY2022, total dividends declared per share were **$2.20** (i.e., 4 × $0.55), confirming consistent quarterly payments throughout the year. [Source 5: CVSHEALTH_2022_10K.pdf, Page 108]

**Bottom line:** CVS Health did pay dividends to common shareholders in Q2 FY2022, at a rate of $0.55 per share for the quarter.
```

### Original gpt-4o-mini judge verdict

- **Verdict:** PASS
- **Reason:** The generated answer accurately conveys that CVS Health paid a $0.55 dividend per share in Q2 of FY2022, matching the gold answer.

### My draft label

- **Draft:** `PASS`
- **Source:** `v1_grader_pass`
- **Reason:** V1 grader marked PASS (gpt-4o-mini judge — not independently re-verified)

### ➤ Your call

**MY VERDICT:** `PASS`

**MY NOTE:** System answer matches the gold answer.

---

## Record 89 of 89  —  `calib_089`  **[CAREFUL REVIEW]**

**Stratum:** `refusal`
**fb_id:** `financebench_id_04417`

### Question

What is the year end FY2019 total amount of inventories for Best Buy? Answer in USD millions. Base your judgments on the information provided primarily in the balance sheet.

### Gold answer

> $5409.00

### System answer (full)

```
I couldn't find relevant information in the available documents to answer your question.
This could mean the information isn't in the documents I have access to, or the question
may need to be rephrased. Could you try asking in a different way?
```

### Original gpt-4o-mini judge verdict

- **Verdict:** FAIL
- **Reason:** The generated answer refuses to provide a specific amount, while the gold answer clearly states a specific figure.

### My draft label

- **Draft:** `FAIL`
- **Source:** `audit_transcription`
- **Reason:** The system declined to answer, citing inability to find relevant information, rather than providing the correct figure of $5,409M — a genuine refusal failure, not a judge artifact.

### ➤ Your call

**MY VERDICT:** `FAIL`

**MY NOTE:** System refuses or cannot provide the definite answer given by the gold answer.

---
